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There continue to be great strides in the field of proteomics but as samples 
become more complex, the ability to increase sequence coverage and confidence in the 
identification becomes more important. Several methods of derivatization have been 
developed that can be used in combination with tandem mass spectrometry to identify 
and characterize proteins. Three types of activation, including infrared multiphoton 
dissociation, ultraviolet photodissociation, and electron transfer dissociation, are 
enhanced in this dissertation and compared to the conventional method of collisional 
induced dissociation (CID) to demonstrate the improved characterization of proteins. 
A free amine reactive phosphate group was synthesized and used to modify the N-
terminus of digested peptides.  This phosphate group absorbs at the IR wavelength of 
10.6 µm as well as the Vacuum-ultraviolet (VUV) due to an aromatic group allowing 
modified peptides to be dissociated by infrared multi-photon dissociation (IRMPD) or 
ultraviolet photodissociation (UVPD) whereas peptides without this chromophore are less 
responsive to IR or UV irradiation.  The PD spectra for these modified peptides yield 
simplified MS/MS spectra due to the neutralization of all N-terminal product ions from 
the incorporation the negatively charged phosphate moiety. This is especially 
 viii 
advantageous for UVPD due to the great number of product ions produced due to the 
higher energy deposition of the UV photons. The MS/MS spectra also produce higher 
sequence coverage in comparison to CID of the modified or unmodified peptides due to 
more informative fragmentation pathways generated upon PD from secondary 
dissociation and an increased ion trapping mass range.   
IRMPD is also implemented for the first time on an orbitrap mass spectrometer to 
achieve high resolution analysis of IR chromophore-derivatized samples as well as top-
down analysis of unmodified proteins.  High resolution/high mass accuracy analysis is 
extremely beneficial for characterization of complex samples due to the likelihood of 
false positives at lower resolutions/accuracies.  
For electron transfer dissociation, precursor ions in higher charge states undergo 
more exothermic electron transfer and thus minimize non-dissociative charge reduction. 
In this dissertation, cysteine side chains are alkylated with a fixed charge to deliberately 
increase the charge states of peptides and improve electron transfer dissociation. ETD can 
also be used to study protein structure by derivatizing the intact structure with a 
hydrazone reagent.  A hydrazone bond will be preferentially cleaved during ETD 
facilitating the recognition of any modified residues through a distinguishing ETD 
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There has been tremendous progress in the field of proteomics in the past decade, 
partly due to advances in mass spectrometric instrumentation and methodology. The 
successful elucidation of the primary sequence of many proteins/peptides through tandem 
mass spectrometry has pushed the development of many complementary dissociation 
methods that allow for more confident and faster identification of proteins and can 
provide information on amino acid mutations, post-translational modifications, and 
tertiary structure of the protein. Even still 75-85% of spectra in a typical MS/MS 
proteomic experiment remain unidentified.P1P This dissertation focuses on the development 
and optimization of selective derivatization to enhance tandem mass spectrometry 
methods for the analysis of proteins/peptides, specifically infrared multiphoton 
dissociation, ultraviolet photodissociation, and electron transfer dissociation.   
 
1.2 TANDEM MASS SPECTROMETRY 
Tandem mass spectrometry (MS/MS) refers to the selection/isolation and 
manipulation (energization or reaction) of a particular precursor ion of interest in which 
both the precursor and resulting product ions are characterized by their mass/charge ratios 
to gather a more detailed account of the precursor ion’s original intact structure.P2P In the 





protein is enzymatically digested producing a set of peptides that are separated using 
liquid chromatography and analyzed by tandem mass spectrometry.P3P The resulting 
fragmentation patterns can be utilized to identify each peptide and in turn the protein.  
There are two current automated algorithm techniques that utilize the fragmentation 
spectra produced upon MS/MS analysis of peptides to identify the protein; in silico and 
de novo sequencing.P4P  In silico algorithms use a large database of known protein 
sequences and compare hypothetical fragmentation spectra for the digested peptides to 
tandem MS spectra of real peptides to find the best match.  De novo sequencing has 
greater impact for unknown protein sequences in that these proteins do not match up to 
any proteins in the in silico databases.  This type of identification is done by searching 
adjacent peaks in a MS/MS spectrum for pairs of ions that have a m/z difference 
equivalent to the m/z of an amino acid. This process is repeated throughout the spectrum 
to sequence the entire peptide.  However, this method can become complicated quickly 
with multiple ion types cluttering a spectrum or limited sequence coverage due to 
selective fragmentation along the backbone.  Without a backbone cleavage between each 
amino acid, only partial sequence information can be determined, thus leading to 
inconclusive identification of the peptide/protein.   
There are several methods of ion activation and dissociation in addition to recent 
advancements in ion-molecule and ion-ion reactions that allow for structural analysis of 
biomolecules.P2, 5, 6P Many of these activation methods are complementary to one another 
providing supplemental data when used cooperatively. No single method has proven to 
be universal for all mass spectrometers and all analyte systems so research into novel 






1.2.1 Proteomic Fragmentation Nomenclature 
Ion activation and dissociation of peptides/proteins typically produces a 
predictable set of cleavages along the amino acid backbone. Therefore a standardized 
nomenclature has been created to ease the identification of these ions where an alphabet 
letter indicates a specific fragment type, dictating the bond being broken, and a subscript 
number indicating the number of amino acid side chains contained in the ion following 
cleavage.P11P An example of this standard nomenclature is shown in Figure 1.1, where a 
four amino acid long peptide with side chains RR1R-RR4,R has been depicted with the most 
common dissociation sites marked. Tandem mass spectrometry typically results in 
cleavages along the peptide backbone as indicated by the lines cutting through a bond. 
For low energy dissociation techniques such as collision induced dissociation (CID) or 
infrared multiphoton dissociation (IRMPD), ergodic fragmentation is achieved through 
heating and the most thermally labile bonds, the backbone amides, are normally cleaved 
producing b and y ions, in which the b-type ion contains the N-terminus and the y-type 
ion contains the complementary C-terminus. An additional loss of CO from the b ion 
produces the associated a ion. Electron based dissociation methods such as electron 
capture dissociation (ECD)P12, 13P and electron transfer dissociation (ETD)P14P produce 
radical driven fragmentation of the N-CRαR bond leading to c- and z- ion types. The 
homolytic backbone cleavage of the CRαR-C bond produced upon  yields a- and x- ion types 
in addition to some secondary side chain cleavages that yield v-, w-, or d-type ions 






Figure 1.1 Peptide/Protein Fragmentation Nomenclature 
 
1.2.2 Collision-Induced Dissociation (CID) 
The most commonly used activation method for proteomic applications is 
collision-induced dissociation in which a selected precursor is activated through 
collisions.P7, 17, 18P  The precursor ion is accelerated by application of a voltage to the mass 
spectrometer that results in energetic collisions with gas molecules, thus converting the 
increased kinetic energy of the ion into internal energy that leads to dissociation. The 
total energy available for the transfer from kinetic energy to internal energy depends on 
the ion’s kinetic energy as well as the mass of the target molecule and precursor ion. In 














































































probability of multiple collisions increases. To ensure multiple energetic collisions, most 
CID experiments are carried out at ~1 mTorr.P19P CID is the most established dissociation 
technique as it can be performed in a wide range of instruments, including time-of-flight 
(TOF), Fourier transform ion cyclotron resonance (FTICR), tandem quadupole and ion 
traps (IT), and is well-suited for multiple analyte types.  However, CID is still not without 
its limitations.  For example, in trapping instruments the rf potential must be ramped to 
increase the kinetic energy of the selected ion.  This rf is also used to trap ions, causing a 
compromise between efficiently activating the precursor and retaining small mass-to-
charge (m/z) fragment ions for detection.P20P  This compromise is known as the low-mass 
cut-off (LMCO) and for most quadrupole ion trap instruments causes the loss of the  
lower fourth of the mass range in relation to the precursor m/z.  In addition, as a resonant 
dissociation method, only the precursor ion is activated and the dominant dissociation 
pathway may be uninformative, such as the loss of small neutral molecule like water or 
NHR3R.  Several stages of MS/MS (commonly referred to as MSPnP) can  be used to 
overcome this problem, where a product ion is subjected to a second stage of activation, 
but these experiments can prove time consuming and result in reduced sensitivity.  
Lastly, as a collision-based method, CID may cause ion losses due to scattering as an 
ion’s motion becomes destabilized from multiple collisions.  For these reasons alternative 
activation methods are being developed as complementary techniques to CID and to 







Photodissociation is an alternative activation method that relies upon exciting an 
ion population through exposure to photons produced from a laser.  Successful 
dissociation is dependent on the ion population’s ability to absorb the photons upon 
irradiation.  Depending on the wavelength used, dissociation can occur following a single 
photon as seen with high energy UV photons (~3-10 eV) or hundreds of photons as with 
low energy IR photons (~0.1 eV).  Low energy IR photons result in vibrational excitation 
similar to that of CID while excitation by a higher energy UV photon leads to electronic 
excitation providing very different dissociation pathways.   
Photodissociation provides many solutions to the limitations discussed previously 
for CID.  For trapping instruments, photodissociation is independent of the rf trapping 
voltage and therefore a broader mass range of product ions can be detected.  In addition, 
as an absorption process, an ion’s motion is not disrupted and ion scattering is greatly 
reduced.  Unlike CID, primary product ions created upon photodissociation may 
simultaneously undergo dissociation as they are also being irradiated, so uninformative 
pathways can be surpassed due to secondary dissociation.  This yields more informative 
fragmentation pathways that were only previously available through MSPnP with CID.   
The efficiency of photon absorption is essential to successful photodissociation 
experiments and can be dramatically influenced by a subtle shift in chemical structure 
such as a substituent or protonation.  While this leads to the great advantage of 
photodissociation being tunable through varied irradiation times, laser power or laser 





However, infrared multiphoton dissociation (IRMPD) is commonly implemented with a 
COR2R laser at λ = 10.6 μm which can be absorbed by a variety of vibrational modes (C-C, 
C-N, C-O, P-O, etc), giving it the potential to have a widespread application base. 
IRMPD has been successful in FTICRs and trapping instruments.P21P  In ion trapping 
instruments, the biggest disadvantage of IRMPD is the competition with collisional 
cooling by the bath gas at optimal trapping pressures (~1 mTorr).  Most analytes can be 
excited by IRMPD but at the general operating pressure for ion traps the rate of 
collisional cooling is nearly equal that of the photon absorption rate, limiting dissociation 
unless a strong chromophore is present.P5, 22P  There have been several methods developed 
to overcome this limitation of IRMPD, including heating the bath gas to decrease 
collisional coolingP23P, applying a supplemental collisional activation to the precursor to 
increase the initial internal energy of precursor prior to irradiationP24P, focusing the laser 
for higher photon energiesP25, 26P, lower the trap pressure so the bath gas is reduced during 
activation,P27, 28P and covalent chemical modification to incorporate a chromophore into the 
structure of the analyte of interest to increase the IR absorption cross-section.P29-33P  Such 
methods will be discussed in this dissertation. 
Ultraviolet photodissociation is gaining interest recently for the analysis of 
biomolecules.  The large range of wavelengths available in the visible and UV range 
allow for the use of a diverse set of lasers that produce photon energies up to 100 times 
greater than those of IRMPD.P34, 35P In particular, aromatic amino acid side chains have 
naturally occurring electronic transitions that can be excited via an excimer laser at 157 
nm (FR2R laser) or 193 nm (ArF laser) and the fourth harmonic of a Nd:YAG laser at 266 





enough to produce fragmentation, yielding a wide array of fragments including a-, and x-
type ions and the unique side chain cleavages that allow for distinction between isobaric 
residues such as Leu and Iso.P35, 40P  However, peptides without aromatic side chains do not 
display as intense absorption of UV photons.  Increasing the aromaticity of these peptides 
through derivatization can lead to increased UVPD and is discussed in chapter 5.    
 
1.2.4  Electron Transfer Dissociation 
Electron-based activation methods are becoming a popular complementary 
technique to CID and have shown great potential in the field of proteomics. The two most 
promising are electron capture dissociationP41P and electron transfer dissociation.P14, 42P  
Electron capture (ECD) was developed in FTICR instruments in which a multiply 
protonated peptide is exposed to a stream of low energy electrons. The capture of an 
electron causes dissociation in a sequence independent manner. ECD requires a large 
population of low energy electrons that cannot be readily trapped in a radio frequency 
field, making it impossible in quadrupole ion traps.P13, 43P In order to implement a similar 
type of dissociation in other trapping instruments, ion/ion reactions are utilized. A reagent 
anion with low electron affinity is reacted with a multiply protonated peptide, and an 
electron is transferred from the anion to the peptide in an exothermic process creating an 
odd-electron species.P14P This activated, charge-reduced species will undergo subsequent 
fragmentation at the N-CRαR bond, similar to ECD, producing c- and z-type fragment ions 
rather than the y- and b-type ions that are produced by thermal dissociation methods like 
CID (see Figure 1.1). This process has been termed electron transfer dissociation (ETD) 





there is little energy redistribution before dissociation, affording more random cleavages 
along the backbone and also allowing retention and identification of post translational 
modifications.P44, 45P All of these distinctions make ETD and ECD complementary to CID.  
As with most methods, ETD also has some disadvantages as well. As electron 
transfer is necessary prior to dissociation, these methods are not suited for singly 
protonated precursors and are more efficient for higher multiply charged precursors (3+, 
4+, 5+, etc.).P46, 47P For doubly protonated precursors, the charge reduced species does not 
undergo efficient dissociation without supplemental activation. There have been methods 
developed to remedy this latter problem such incorporation of additional charges into the 
structure or the application of a supplemental collision activation step to apply a small 
amount of energy to excite the charge reduced species triggering dissociation.P48-55P 
Another method to bypass this shortcoming through the incorporation of additional 
charges is discussed in chapter 4.   
 
1.3 SELECTIVE DERIVATIZATION 
The most common proteomics protocol for mass spectrometry involves a bottom-
up approach for identification as shown in Figure 1.2, often involving complex mixtures 
of proteins from cells or tissues.P2, 56P A cell lysate releases thousands of proteins, lipids, 
DNA and biological materials. A group of the separated proteins can then be 
enzymatically digested and separated/analyzed by LC MS/MS. Subsequent protein 
identification is achieved using database searching of the MS/MS data recorded in an in 












Figure 1.2 General Protocol for Bottom-up Mass Spectrometry; 1. Cell is lysed to 
release all biological material; 2. Biological material is separated; 3. 
Excision of a group or single protein; 4. Protein enzymatically digested; 5. 
Digested peptides are separated through LC/ESI-MS; 6. Individual 
peptides analyzed through MS/MS; 7. MS/MS spectra are submitted to a 
software algorithm for identification.   
 
 However, even a fraction of the original cell lysate may contain a large number 
of proteins, which when digested can increase the sample complexity by several orders of 
magnitude limiting the performance of current methods employed for protein 
identification. One method that can simplify the analysis of these complex samples is 
selective derivatization.P29, 57-63P Chemical derivatization allows a specific group of 




































analytes with the same functional group to be targeted limiting the potential candidates 
for protein identification. In combination with a selective affinity extraction method, 
chemical derivatization can be used to decrease the complexity of the sample. For 
example, cysteines are only present in 17% of the tryptic peptides produced from the 
human proteome but over 89% of proteins contain at least one cysteine residue.P60P If only 
cysteine peptides are enriched from a complex mixture for analysis, then a large amount 
of the proteome can be identified through the analysis of a small number of peptides. If a 
reaction is selective for only thiol groups, then cysteine residues can be selectively 
modified and enriched through separation techniques leading to increased detection 
sensitivity for the modified peptides.   
In addition, selective derivatization can be utilized to incorporate a functional 
group that can enhance mass spectrometric analysis.P64, 65P Electrospray ionization is one of 
the most amenable ionization techniques for proteomic analysis because it is a soft 
ionization technique meaning that the parent molecule is ionized without causing 
fragmentation in the process. This is important for proteomic studies so that the 
molecular weight of the original protein can be easily established. The large number of 
basic residues present in proteins (Lys, Arg and His) make positive ionization of proteins 
a favorable process. However, additional charges incorporated through derivatization, 
whether they are positive or negative, can enhance both the initial ionization of the 
protein, increasing sensitivity, and the subsequent fragmentation of the protein for more 
confident identification of the protein through increased sequence coverage.P66P 
Dissociation can also be altered through derivatization.P67-70P As already mentioned, 





absorb photons of a certain wavelength, thus enhancing photodissociation or the creation 
of a completely new set of fragment ions through ultraviolet photodissociation.   
Selective covalent labeling has also been used to study the tertiary structure of 
proteins and their interactions with other proteins through a measure of reactivity.P58, 71-74P 
In addition to the affinity of the reagent for the amino acid, an amino acid’s reactivity is 
based on the accessibility of its side chain to the reagent. Upon reaction, the extent of 
reaction for each possible amino acid can be compared and related to its position in the 
tertiary structure of the protein in terms of relative surface accessibility.P71P The surface 
accessibility information can be used to place constraints on the positions of the reacted 
amino acids and to predict the three-dimensional structure of a protein.  This technique 
can also be used to investigate protein complexes if upon a protein-protein/protein-ligand 
interaction a conformational change occurs affecting the extent of accessibility of certain 
amino acids and changing their reactivity with the labeling reagent.  If a change in 
accessibility occurs upon interaction (whether it be an increase or decrease), it is 
indicative of the involvement of that amino acid in a structural change and/or the location 
of that amino acid at the binding site.P71P  
Although monitoring the reactivity of an intact protein by MS is quick and simple, 
the amount of information gleemed is not as detailed as that produced upon analysis of 
the enzymatically digested peptides produced following modification.  Therefore the 
typical protocol for studying the structure of a protein using MS is to react the labeling 
reagent with the intact protein in solution followed by a bottom-up MS/MS approach as 






Figure 1.3 General Protocol for Surface Accessibility Study with MS; 1. Intact 
protein is labeled in solution and desalted; 2. Modified protein is 
enzymatically digested; 3. Digested peptides are separated and analyzed 
with LC/ESI-MS; 4. Modified peptides are identified by a characteristic 
MS/MS spectrum; 5. Modified peptides identified using MSPnP. 
 
Enzymatic digestion adds complexity to a sample and the introduction of possible 
modification sites will increase the intricacy of data analysis even more.  Since 
identification of the modification sites is the key outcome in this type of analysis, it 
would be beneficial to be able to quickly separate all labeled peptides from those 
unmodified to eliminate a large part of the peptide population needing to be analyzed.  
One strategy to quickly pinpoint the modified peptides is through the use a characteristic 






P E P T I








CID to quickly identify which peptides have been modified from the complex digest 
mixture and then utilize a MSPnP stage to further interrogate the peptide.P64, 75-78P 
 
1.4 OVERVIEW OF CHAPTERS 
 The focus of the research discussed in this dissertation is the development of 
derivatization methods that will selectively modify peptides or proteins with the aims of 
improving the sequencing or structural analysis. Derivatization methods can be utilized to 
attach chromophores, additional charges or mass tags that can be used to improve 
dissociation efficiency, increase ionization efficiency, or provide the means to improve 
separation from other components in a complex mixture. 
 Photodissociation offers key advantages to improve dissociation spectra of 
biomolecules. An IR chromophore with reactivity that is selective for free amines 
(Lysines and the N-terminus) was synthesized to increase the photoabsorptivity of tryptic 
peptides (Chapter 3). Upon tryptic digestion, most peptides will contain a lysine in the 
sequence, thus providing a convenient site of modification for each peptide allowing 
efficient dissociation upon IR irradiation. The modification of lysines with a phosphate 
chromophore can extend the use of IRMPD to cover a larger population of analytes for 
bottom-up proteomics.   
High resolution instruments have expanded the potential for mass spectrometric 
analysis of large and small molecules. The increased mass accuracy allows for confident 
assignment of chemical formula for small molecules and a deconvoluted spectrum of 
higher charged species providing a facile method for determining its molecular weight. 





resolution instruments like the FTICR. But until the emergence of the Orbitrap providing 
high resolution at a lower price tag, the possibility of obtaining photodissociation with 
high mass accuracy and resolution to the masses has not been possible. Through the 
incorporation of an IR laser into the higher collision dissociation (HCD) cell, IRMPD in 
an orbitrap can be utilized to study chromophore enhanced or supercharged peptides for 
bottom-up proteomics and highly charged intact proteins for top-down analysis (Chapter 
4). 
Ultraviolet photodissociation provides higher energy deposition than IRMPD, 
promoting high energy fragmentation pathways. Aromatic residues have proven to be a 
natural UV chromophore promoting highly efficient UVPD spectra. However, peptides 
without aromatic residues provide minimal fragmentation that is not conducive to 
sequencing peptides. Through the attachment of an aromatic substituent, UVPD can be 
enhanced providing high energy fragmentation spectra for all peptides (Chapter 5). In 
addition a negative charge fixed on to the modification site can limit the type of fragment 
ions produced, leading to simplified fragmentation spectra. The same phosphate aromatic 
chromophore used to improve IRMPD in Chapter 3 can be used to enhance UVPD 
through the incorporation of an aromatic chromophore while the negatively charged 
phosphate substituent will neutralize many of the singly charged fragment ions that 
contain the modification.   
Electron transfer dissociation has been shown to be a complementary dissociation 
technique to collision induced dissociation. CID is better suited for low charge states 
(singly and doubly charged species) while ETD of low charged species leads to only 





sequence information. Through the addition of a fixed charge to all reduced Cys residue, 
the ETD efficiency of all Cys peptides can be increased (Chapter 6). Ions in higher 
charge states promote more efficient formation of the diagnostic c- and z-type ions, 
leading to better sensitivity and increased confidence in peptide and protein 
identifications.  
Finally, structural analysis of proteins is of great importance as it can give insight 
into the protein’s function. Mass spectrometry in combination with surface accessibility 
methods yields low resolution structural information about a protein’s surface in which 
selective derivatization of the native protein is used to mark key amino acids on the 
surface of a protein to distinguish them from the interior of the protein structure. After 
derivatization, the protein is typically subjected to proteolytic digestion and LCMS/MS 
analysis in which the peptides containing the surface accessibility tag are present amidst a 
large number of unmodified peptides.  With a complex mixture of peptides containing 
both modified and unmodified ones, a method that allows for quick distinction between 
the two is desirable.  It has been shown that a N-N hydrazone bond is preferentially 
cleaved by ETD. A novel Lys selective modification reagent that incorporates a N-N 
hydrazone bond onto all free amines was synthesized (Chapter 8). Due to the preferential 
cleavage of the N-N bond upon ETD, any modified species can be easily distinguished 
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2.1 MASS SPECTROMETRY 
Two types of mass spectrometers were utilized in the work discussed in this 
dissertation, with all using electrospray ionization (ESI) for generation of ions. The 
majority of the work was conducted on a ThermoFisher Scientific LTQ XL linear ion trap 
(San Jose, CA) modified for photodissociation and electron transfer dissociation.  The 
geometry of a linear ion trap allows for an increased storage capacity of ions offering 
improved sensitivity in comparison to 3D quadrupoles. A linear ion trap consists of four 
rods arranged in a quadrupole and split into three sections with apertures on the front and 
back ends of the quadrupole.  RF voltages are applied on the front and back sections of 
the quadrupole to confine the ions radially and can be raised and lowered to bring ions 
into the trap and move them through the trap.  The ions are ejected radially through slits 
in the rods as the RF voltages are raised according to their m/z ratio with the smallest 
ions being moved first followed by the larger ions.  Two electron multiplier detectors are 
positioned on either side of the ion trap to detect the ions as they are ejected from the ion 
trap.  A Bruker MaXis time-of-flight mass spectrometer was also used for some 
experiments in this dissertation.  A time-of-flight mass spectrometer uses differences in 
travel time through a field free drift tube to separate ions based on their mass-to-charge 
ratio. A strong electric field accelerates a population of ions from the same place at the 





lighter ions will have a higher velocity than heavier ions and will reach the detector at the 
end of the drift tube at a faster rate.   
ESI is a soft ionization source meaning that it produces ions without causing 
fragmentation so the mass of the initial analyte can be easily determined.  Ions are 
produced by applying a potential to a heated capillary through which the analyte and a 
nitrogen gas flows, both nebulizing and desolvating the sample to produce multiply 
charged analyte ions.  This heated capillary is maintained at 180 °C for all experiments to 
promote desolvation.  Protein and peptide samples were typically run at 10 µM in 
49.5:49.4:1 HR2RO/MeOH/acetic acid (v/v/v). 
 
2.2 INFRARED MULTIPHOTON DISSOCIATION (IRMPD) 
IRMPD experiments were performed on a modified LTQ and modified Orbitrap mass 
spectrometers. The LTQ was modified through the introduction of a CF viewport flange with 
a ZnSe window with an anti-reflective argon coating in place of the vacuum manifold back 
flange to allow introduction of the 10.6 µm radiation. A 48-5 Synrad 50 W CO2 continuous 
wave laser (Mukilteo, WA) was triggered during ion activation using a TTL signal from pin 
14 of the J1 connector and controlled through instrument software.  The laser beam was 
passed through a 1.8 mm aperture that was mounted to the back flange and a 2 mm aperture 
of the exit lens prior to reaching the ion cloud in the linear ion trap.    For the orbitrap, 
IRMPD was performed in the HCD cell of a modified hybrid mass spectrometer comprising 
both linear ion trap and orbitrap mass analyzers. The HCD manifold was modified via the 
addition of a ZnSe window co-axial with the HCD cell and opening an aperture (d = ~2.54 





photons. Additionally, a nitrogen gas line was installed in the C-trap and the top and bottom 
of the C-trap were fitted with ceramic plates to decrease gas conductance out of the C-trap, 
reducing the gas flow needed to achieve desired trapping efficiencies in the C-trap while 
minimizing the NR2R partial pressure in the QLT (quadrupole linear trap).  Taken as a whole, 
these modifications allowed substantially independent control of nitrogen gas flow to both 
the C-trap and HCD cell.  A 100 W Synrad COR2R laser was directed in the HCD cell using two 
optic mirrors mounted behind the HCD cell. All experiments were conducted using 50 W 
power with irradiation times varying between 1 and 200 ms.  A low activation qRzR-value 
(≤0.2) was used to minimize the low mass cut-off.  
 
2.3 ULTRAVIOLET PHOTODISSOCIATION 
UVPD was performed on a a ThermoFinnigan LTQ XL linear ion trap mass 
spectrometer using a Coherent Excistar XS 500 ArF excimer laser (Munich, Germany) 
with a repetition rate of 500 Hz and a pulse width of 5 ns.  A mixture of argon and a 
small amount of fluorine was used as the active laser medium.  Most UVPD irradiation 
was done with a single laser pulse triggered through the LTQ software as described above 
for IRMPD with the lowest possible activation setting on the LTQ software, 0.03 ms.  All 
experiments were conducted using an energy of 1 to 6 mJ and was controlled with the 
Excistar software.  The laser beam was introduced through the a CF viewport flange in 
place of the vacuum manifold back flange with a CaFR2R window with an anti-reflective 
193 nm coating to allow complete transmission of the 193 nm laser.  The activation qRzR-






2.4 ELECTRON TRANSFER DISSOCIATION 
ETD experiments were performed on the LTQ XL two dimensional linear ion trap 
and MaXis time-of-flight mass spectrometers.  Fluoranthene anions were used as the 
reagent anion in both instruments. The reagent anion population was varied between 1 x 
10P5P to 1 x 10P6P ions and generated by chemical ionization prior to being directed into the 
trap. All ion-ion reaction times varied between 100 and 250 ms. 
 
2.5 CHEMICALS AND REAGENTS 
All chemicals were purchased from Sigma Aldrich (St. Louis, MO) except for the 
following peptides which were obtained from BACHEM (King of Prussia, PA): 
FQVVCG, HCKFWW, CDPGYIGSR, NRCSQGSCWN, somatostatin 
(AGCKNFFWKTFTSC), LQVQLSIR, YGGFLK, FSWGAEGQR, bradykinin 
(RPPGFSPFR),  TGF-alpha (CHSGYVGVRC), bactenecin (RLCRIVVIRVCR), amyloid 
protein 1-16 (DAEFRHDSGYQVHHQK), ASHLGLAR, YRPPGFSPFR, 
GNHWAVGHLM, MEHFRWG, and RQpSVELHSPQSLPR.  HSDAVFTDNYTR and 
fibrinopeptide a (ADSGEGDFLAEGGGVR) was obtained from the American Peptide 
Co. (Sunnyvale, CA). Angiotensin I(DRVYIHPFHL), ubiquitin (bovine red blood cells), 
cytochrome c (equine heart), and BSA were purchased from Sigma (St. Louis, MO). 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC), succinimidyl 4-
formylbenzoate (SFB), and immobilized trypsin beads were obtained from Pierce 
Biotechnology (Rockford, IL).  GluC was purchased from New England BioLabs Inc. 
(Ipswich, MA).  Water, acetonitrile, acetic acid and formic acid were all purchased from 







2.6 CHEMICAL SYNTHESIS 
For the work described in this dissertation, a number of custom compounds were 
designed and synthesized.   
2.6.1 Synthesis of 4-methylphosphonophenyl Isothiocyanate (PPITC) 
 4-methylphosphonophenylisothiocyanate was synthesized to selectively add a 
phosphate chromophore at all free amines including lysine side chains and the N-
terminus of digested peptides to increase their energy absorption of 10.6 µm wavelength.  
To synthesize PPITC, 4-Bromophenylisothiocyanate was refluxed for 30 minutes with 2x 
triethylphosphite after which the product was purified on a silica column with 50:50 
DCM:MeOH and dried to isolate the diethyl ester form. The ester form was converted to 
the acidic form by reaction with 3.5 equivalents of bromotrimethylsilane which was 
added drop-wise and allowed to stir at room temperature for 24 hours. The reaction 
mixture was dried on a rotovap, and the product was dissolved in minimal MeOH. This 
product was allowed to stir at room temperature for an additional four hours and then 
dried on a rotovap and concentrated under reduced pressure. 
 
2.6.2 Synthesis of 2, 5,-dioxo-1-((4-((2-(pyridine-2-yl)hydrazono)methyl)benzoyl) 
oxy) pyrrolidine-3-sulfonic acid (NN) 
 The surface accessibility reagent, NN, was synthesized by by refluxing 7.3 mmol 
of 2-hydrazinopyridine and 9.7 mmol of 4-formylbenzoic acid in 20 mL of toluene for 





toluene and ethyl acetate (82.0%). One equivalent of the isolated hydrazonal intermediate 
was coupled with two equivalents of N-hydroxysulfosuccinimide using two equivalents 
of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide and a catalytic amount of 4-
dimethylaminopyridine in dimethylformamide for 24 hours. Upon completion, the 
reaction was rotovaped and washed with dichloromethane and water. The product was 
titurated in hexanes before isolating a dark yellow solid (46.8%).   
 
2.7  SELECTIVE DERIVATIZATION 
2.7.1 Free Amine Modifications 
 Free amines are prime canidates for peptide/protein modification because they 
occur regularly (lysine side chains and N-terminus) and are broadly susceptible to a 
number of reactions. 
 
2.7.1.1 Phenyl Isothiocyanate (PITC) and 4-Sulfophenyl Isothiocyanate (SPITC)  
 20 µL of a 10 µg/µL solution of reagent solution buffered to a pH of 9.5 
with 20 mM NaHCOR3R was incubated with 10 µL of 1 mM peptide solution for 30 
minutes at 55º C.  The reaction was terminated with an addition of 1.5 µL of 5% 
trifluoroacetic acid, and then derivatized product was purified on a C18 spin column. 
 
2.7.1.2 4-methylphosphonophenyl Isothiocyanate (PPITC) 
 20 µL of a 10 µg/µL solution of reagent solution buffered to a pH of 9.5 with 20 





NaHCOR3R (pH 8 – 9) and 70 µL water for 30 minutes at 55º C.  The product was purified 
on a C18 spin column and diluted to 10 µM prior to ESI analysis. 
 
2.7.1.3 2,5,-dioxo-1-((4-((2-(pyridine-2-yl)hydrazono)methyl)benzoyl)oxy) 
pyrrolidine-3-sulfonic acid (NN) 
 Each protein (1 mM, 25µL) was mixed with NN at a variety of molar ratios 
relative to NN (20 mM) in PBS buffer at pH 7.2 - 7.4.  The protein:NN ratios were varied 
from 1:2 to 1:10.   All reactions were carried out at room temperature overnight and 
cleaned up using 10 kDa MWCO filters the following morning.    
 
2.7.2 Cysteine Alkylations 
All disulfide bonds in the peptides or proteins were first reduced by adding a 5-
fold molar excess of dithiothreitol (DTT) to the peptide or protein (10 μL, 1 mM) in 
aqueous solution and incubating at 40 °C for 1 hr in the dark (per manufacturer’s 
recommended protocol for optimal efficiency). After alkylation all peptides were desalted 
using Thermo Fisher PepClean CR18R spin columns and diluted for MS analysis as 
described above.   
 
2.7.2.1 Iodoacetamide (IAM) 
IAM-alkylation was performed by adding iodoacetamide (4 μL, 1 M) in 
ammonium bicarbonate buffer (pH ~8.0, 100 mM). This reaction was allowed to proceed 





quench the alkylation reaction. The resulting products are ones in which the reduced 
thiols are converted to S-carboxamidomethyl groups. 
 
2.7.2.2 Dimethyl Lysine (DML) 
 DML modifications were initiated by reacting N,N-dimethyl-2-chloro-ethylamine 
(1 μL, 1 mM in 1M HEPES buffer, pH 7.8) for three hours at room temperature, 
producing carboxyamidomethyl cysteines. 
 
2.7.2.3 (3-acrylamidopropyl)-trimethyl ammonium chloride (APTA) 
 APTA derivatization was achieved by reacting the reduced peptide solution with 
APTA (16 μL, 1 mg/mL in 50:50 ACN/ 100 mM ammonium bicarbonate buffer, pH 8.0) 
overnight at room temperature in the dark followed by freezing to terminate the reaction. 
The resulting products are fixed-charge trimethylammonium S-alkyl cysteine derivatives. 
 
2.8 ENZYMATIC DIGESTION 
2.8.1 Trypsin 
 Trypsin digestion produces enzymatically cleaved peptides with a C-terminal 
lysine or arginine amino acid when proline is not the neighboring residue.  Due to the 
abundance of lysine and arginine residues, trypsin produces smaller peptides that upon 
ESI normally reside in the 1+, 2+ and 3+ charge states.  Proteins diluted in 100 mM 
NHR4RHCOR3R are digested using 1 mg/mL proteomics grade trypsin (Sigma-Aldrich, St. 





terminated with a small addition of 1.5 μL 5% trifluoroacetic acid and diluted to 10 μM 
before ESI analysis with 49.5/49.5/1 HR2RO/MeOH/acetic Acid.   
 
2.8.2 ArgC 
 ArgC digestion leads to cleavage on the C-terminal side of arginine residues.  By 
eliminating cleavage following lysine residues ArgC produces much larger peptides to be 
analyzed by ESI.  Proteins are diluted in 100 mM NHR4RHCOR3R with a small addition of Ca 
acetate to promote efficient digestion and mixed with 1 mM ArgC solution at a 1:16 
protein to enzyme w/w ratio. Reactions are allowed to go overnight at 37 PoPC. Digested 




 Endoproteinase GluC is a serine protease that cleaves selectively on the C-
terminal side of glutamic acid.  Digestions are carried out in 50 mM Tris-HCl, 0.5 mM 
Glu-Glu buffer at pH 8.0 at a 1:20 protein to enzyme w/w ratio overnight at 25 PoPC. 
Digested samples are diluted to 10 μM before ESI analysis with 49.5/49.5/1 
HR2RO/MeOH/acetic Acid. 
 
2.9 LIQUID CHROMATOGRAPHY 
 For complex samples, such as a protein digest, separation of the mixture is often 
advantageous prior to mass spectrometric analysis to increase the sensitivity.  Most 





chromatography separates and desalts complex samples based on the polarity and size of 
the different analytes and is easily adapted to mass spectral analysis. A Dionex Ultimate 
3000 cap/nano HPLC system (Sunnyvale, CA) with a reverse phase Agilent ZORBAX 
300SB-CR18R column (Santa Clara, CA) (150 × 0.3 mm, 5 µm particle size) was used for all 
separations. The column temperature was kept constant throughout the run at 40°C. 
Eluent A consisted of 0.1% formic acid in water and eluent B was 0.1% formic acid in 
acetonitrile. A linear gradient from 5% eluent B to 40% eluent B over 65 min at 5 µL/min 
was used for all capillary-LC runs while 0.3 µL was used for nano-LC runs. Injections of 
approximately 1 µg were used for all samples.   
 
2.10 DATABASE SEARCHING 
 In most proteomic applications using LC-MS/MS analysis, the vast amount of 
data collected is subjected to automated database searching to identify the sample.  
Typically, the experimental MS/MS spectra are searched against a library of theoretical 
spectra that are generated from known protein sequences and then scored based on how 
well they matched up and the ability to distinguish between true positives and false 
positives. SEQUEST was used for all database searching experiments through the 
ThermoFisher Scientific Proteome Discoverer 1.0 software.  For all SEQUEST 
calculations the following parameters were used; signal/noise ratio of 3, a precursor mass 
tolerance of 1.5 Da, a fragment mass tolerance of 0.8 Da and all peptide hits were filtered 
against a false discovery rate (FDR) of 1%. All experimental derivatizations were set as 
dynamic modifications based on their associated mass shifts.  Oxidation of methionines 





a, b, c, x, y, and z product ions were used, for ETD experiments c and z product ions were 
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Improved Infrared Multiphoton Dissociation of Peptides through N-
Terminal Phosphonite Derivatization Experimental  
 
3.1 OVERVIEW 
A strategy for improving the sequencing of peptides by infrared multiphoton 
dissociation (IRMPD) in a linear ion trap mass spectrometer is described. We have 
developed an N-terminal derivatization reagent, 4-methylphosphonophenylisothiocyanate 
(PPITC), which allows the attachment of an IR-chromogenic phosphonite group to the N-
terminus of peptides, thus enhancing their IRMPD efficiencies. After the facile 
derivatization process, the PPITC modified peptides require shorter irradiation times for 
efficient IRMPD and yield extensive series of y ions, including those of low m/z that are 
not detected upon traditional CID. The resulting IRMPD mass spectra afford more 
complete sequence coverage for both model peptides and tryptic peptides from 
cytochrome c. We compare the effectiveness of this derivatization/IRMPD approach to 
that of a common N-terminal sulfonation reaction that utilizes 4-
sulfophenylisothiocyanate (SPITC) in conjunction with CID and IRMPD. 
 
3.2 INTRODUCTION 
In recent years, there has been tremendous effort devoted to the application of 
mass spectrometry to the field of proteomicsP1, 2P in large part because of the success of 
tandem mass spectrometry for elucidation of primary sequences and modifications of 





context, including collision induced dissociation (CID),P8, 9P electron capture dissociation 
(ECD),P10P electron transfer dissociation (ETD),P11P pulsed-Q dissociation (PQD),P12P surface 
induced dissociationP13P and photodissociation (PD).P14-19P Each method has its own 
particular strengths and shortcomings, with CID being the most widely used due to its 
relatively well-understood underpinnings. However, the resulting CID mass spectra can 
be cluttered with redundant b and y ions, as well as ions created by uninformative losses 
of small organic molecules like water and ammonia. Hence, the interpretation of such 
data manually or via de novo algorithms remains challenging.P20, 21P ECD and ETD provide 
complementary c and z ions and have proven more useful for tracking post-translational 
modifications (PTMs); however, these activation methods generally offer lower 
dissociation efficiencies than CID and are highly dependent on the charge state of the 
selected precursor ion.P10, 11P  PD methods, including both infrared multiphoton 
dissociation (IRMPD) and ultraviolet photodissociation (UVPD), have also shown 
promise because of their potential for high energy deposition and tunability.P14-19, 22-35P 
Since photoabsorption is not a collision-based process, it does not alter the kinetic 
energies of ions and thus minimizes any ion losses due to scattering. 
Photodissociation also offers particular advantages for ion trap mass 
spectrometers. For example, photoactivation is independent of the trapping voltage, 
unlike CID. In CID, the rf voltage during ion activation influences the energy deposition 
of collisional activation as well as defines the lower m/z range. The potential for greater 
energy deposition in CID occurs at the expense of storage of lower m/z ions, ones which 
might be key diagnostic ions for sequencing peptides. PQD is another collision based 





during CID in ion trap mass spectrometers. For PQD, the rf voltages applied during ion 
activation and subsequent ion trapping are quickly manipulated to avoid ejection of all 
the lower m/z fragment ions.P12P However, the dissociation efficiency for PQD, in terms of 
the conversion of precursor ions to fragment ions, is rather low. Despite this impressive 
array of ion activation methods, the quest for more efficient and more selective strategies 
continues to be an important goal in the development of mass spectrometric-based 
proteomics, especially in order to simplify spectral interpretation and improve the 
identification of post-translational modifications.   
One approach entails derivatization of proteins or peptides to facilitate their 
enrichment in complex mixtures,P36-39P to alter their charge states to direct fragmentation 
pathways,P16P  or to attach chromophores to enhance their photoabsorptivity.P14-16, 29, 32, 40, 41P 
For example, N-terminal sulfonation reactions have proven to simplify the MS/MS 
spectra of peptides by introducing a fixed negative charge at the N-terminus.P42-45P This 
sulfonate addition leads to neutralization of the normally singly charged b ions created 
upon dissociation of peptides, resulting in series of easily interpreted y ions. In particular, 
4-sulfophenylisothiocyanate (SPITC) has shown great potential as a reagent for this 
process because it is inexpensive, stable, and extremely efficient in reacting with the N-
terminus of peptides.P43, 45, 46P Upon CID the dominant product ion for the SPITC-
derivatized peptides is typically the yRn-1R ion due to the loss of the sulfanilic acid and the 
N-terminal amino acid which is catalyzed by the labile proton from the sulfonic group 
that promotes a specific Edman-type cleavage.P43P Another N-terminal sulfonation reagent, 
2-sulfobenzoic acid cyclic anhydride, also introduces a negative charge at the N-termini 





afforded by the SPITC-derivatized peptides.P16P The newest N-terminal sulfonation 
reagent, 4-chlorosulfophenyl isocyanate, also results in more uniform arrays of y ions 
from the peptides, albeit with higher critical energies.P46P PITC is another N-terminal 
reagent that affords a good chromophore at 266 nm for UVPD, and the resulting PITC-
peptides yield both b and y sequence ions.P47P The same SPITC-derivatized peptides 
produce only y ions upon UVPD, again with notable enhancement of the yRn-1R ion.P47P   
We have been developing derivatization agents for biological molecules that 
increase their photoabsorptivities in the gas phase and/or alter the fragmentation patterns 
of the resulting ions to give more informative or more easily interpreted mass spectra. For 
example, we recently combined an N-terminal sulfonation procedure with IRMPD in a 
quadrupole ion trap to allow detection of entire series of y ions for tryptic peptides, thus 
allowing successful de novo sequencing.P16 PWe have also developed other IR-
chromogenic ligands to improve IRMPD efficiencies, including phosphorylated pyridyl 
ligands that form metal complexes with flavonoids,P41P a boronic acid reagent that 
selectively binds to the diol functionality of oligosaccharides and improves the 
determination of their sequences,P40P  and a new phosphorylated crosslinking reagent that 
allows the differentiation of crosslinked peptides from non-crosslinked peptides for 
elucidation of contact points in proteins.P48P We have also explored UV-chromogenic 
reagents in conjunction with UVPD for sequencing peptidesP15P and a reductive amination 
procedure that incorporates fluorescent labels into oligosaccharides to improve UVPD 
efficiencies.P14P The successful outcomes of these previous strategies that combined 
derivatization with photodissociation have motivated our efforts to expand the arsenal of 





  In this chapter we report a new N-terminal derivatization reagent that 
incorporates a phosphonite functionality. The new reagent, 4-
methylphosphonophenylisothiocyanate (PPITC), was designed specifically to provide a 
negative charge site similar to the sulfonated reagents, in addition to containing a strong 
IR chromophore to enhance the photoabsorptivity at a wavelength of 10.6 µm of the 
resulting derivatized peptides. It has been shown previously that phosphorylated peptides 
possess high photoabsorptivities at 10.6 µm which is critical for successful IRMPD.P23, 49-
51
P Here we compare the IRMPD efficiencies and the number of diagnostic sequence ions 
obtained for a series of peptides derivatized by SPITC, PPITC, and PITC (Figure 1). 
 
3.3 EXPERIMENTAL 
3.3.1 Materials and Reagents 
All chemicals were purchased from Sigma Aldrich (St. Louis, MO) except the 
following peptides which were obtained from BACHEM (King of Prussia, PA): 
LQVQLSIR (H-4588), FSWGAEGQR (H-2680), Amyloid protein 1-16, and YGGFLK 
(H-2765) and from American Peptide Co. (Sunnyvale, CA): HSDAVFTDNYTR (48-1-
12) and Fibrinopeptide A (42-1-12A). 
 
3.3.2 Synthesis of 4-methylphosphonophenylisothiocyanate (PPITC) 
4-Bromophenylisothiocyanate was refluxed for 30 minutes with 2x 
triethylphosphite after which the product was purified on a silica column with 50:50 
DCM:MeOH and dried to isolate the diethyl ester form. The ester form was converted to 





added drop-wise and allowed to stir at room temperature for 24 hours. The reaction 
mixture was dried on a rotovap, and the product was dissolved in minimal MeOH. This 
product was allowed to stir at room temperature for an additional four hours and then 
dried on a rotovap and concentrated under reduced pressure. The PPITC structure was 
confirmed by P1PH NMR using a 400 MHz Varian instrument. P1PH NMR at 400 MHz in 
CDR3ROD yielded: 7.21 ppm (d, 2H), 7.40 ppm (d, 2H), 3.17 ppm (s, 2H), 3.19 ppm (s, 
1H); these findings are consistent with the proposed structure.   
 
3.3.3 PITC Derivatization of Peptides 
PITC and SPITC protocol:  20 µL of a 10 µg/µL solution of reagent solution 
buffered to a pH of 9.5 with 20 mM NaHCOR3R was incubated with 10 µL of 1 mM peptide 
solution for 30 minutes at 55º C.  The reaction was terminated with an addition of 1.5 µL 
of 5% trifluoroacetic acid, and then derivatized product was purified on a C18 spin 
column. 
PPITC protocol:  20 µL of a 10 µg/µL solution of reagent solution buffered to a 
pH of 9.5 with 20 mM NaHCOR3R was incubated with 10 µL of 1 mM peptide solution, 60 
µL 100 mM NaHCOR3R (pH 8 – 9) and 70 µL water for 30 minutes at 55º C.  The product 
was purified on a C18 spin column and diluted to 10 µM prior to ESI analysis.  
 
3.3.4 Mass Spectrometry 
All experiments were performed on a ThermoFinnigan LTQ XL linear ion trap 
mass spectrometer equipped with a standard ESI source. The LTQ mass spectrometer 





rate of 3 µL/min at a concentration of 10 µM in 100% MeOH. For CID, the precursor 
was activated for 30 ms at a standard qRzR value of 0.25. Energy-variable CID experiments 
were performed by incrementally raising the applied CID voltage. All CID experiments 
were recorded in triplicate on the same day. In cases where CID voltages are reported, the 
CID voltages required to cause dissociation of 50% of the selected precursor ions were 
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where the degrees of freedom is defined as N = 3n – 6, and n is the number of atoms in 
the underivatized peptide.P52P 
 
3.3.5 Infrared Multiphoton Dissociation 
IRMPD experiments were performed using a 48-5 Synrad 50-W continuous wave 
CO2 laser (Mukilteo, WA). The laser was directed through the back end of the vacuum 
manifold that was modified with a CF view port flange equipped with a ZnSe window to 
allow the 10.6 μm radiation into the ion trap.P48P This port was aligned so that the beam 
was on axis with a 1.7 mm entrance aperture and the 2 mm aperture of the exit lens of the 
ion trap. The unfocused laser was controlled using a TTL signal setup in the instrument 
software to trigger during activation. All IRMPD experiments were performed using a 
reduced qRzR value of 0.1 to allow for sufficient detection of the low-mass ions and 
irradiation times of ~5 to 200 ms at 50 W unless otherwise noted. The helium pressure 
was maintained at the normal operating pressure. Time-variable IRMPD experiments 






3.4 RESULTS AND DISCUSSION 
3.4.1 Design and Reactions of PPITC 
 We have previously shown that combining IRMPD with an N-terminal 
sulfonation procedure substantially improved the de novo sequencing of peptides, 
primarily by eliminating the redundant b ion series that can make it difficult to pinpoint 
the y ions and also by extending the series of y ions detected via alleviation of the low 
mass cut-off typically encountered upon conventional CID.P16P The promising results 
obtained in this prior study motivated us to design a new N-terminal derivatization 
reagent that would specifically contain an IR chromophore to enhance the absorption of 
10.6 µm photons, thus making the peptides even more amenable to IRMPD. In addition, 
the new reagent was designed to afford a fixed negative charge site at the N-terminus to 
encourage the neutralization of all b fragments, yielding y-rich fragmentation patterns 
similar to what has been seen previously following derivatizations of peptides with 
SPITC.P43, 45, 46P The negative phosphonite group fixed at the N-terminus would neutralize 
any N-terminal ions created through tandem excitation leaving solely C-terminal ions 
represented in the resulting MS/MS spectrum, which for both CID and IRMPD is 
predominantly the y ion cleavage. The phosphono-PITC reagent shown in Figure 3.1 
resulted in the attainment of both goals. The phosphonite group was incorporated on the 
PITC skeleton via a two-step modification of 4-bromophenylisothiocyanate. Subsequent 
reaction of PPITC with individual peptides or mixtures of tryptic peptides occurred with 





peptides for IRMPD. In comparison, the average yields for derivatization of the same 







Figure 3.1 PITC complexes; (1) 4-Sulfophenylisothiocyanate (SPITC), (2) 





3.4.2 CID and IRMPD of PITC-Derivatized Peptides 
Examples of the CID and IRMPD mass spectra obtained for the underivatized and 
the corresponding PPITC-derivatized peptides are shown in Figure 3.2 and Figure 3.3. 
The CID mass spectrum of the first protonated peptide, FSWGAEGQR, is dominated by 





abundances (Figure 3.2A). Moreover, the spectrum is cluttered with both b and y ions 
that offer redundant and yet incomplete sequence information, in addition to additional 
confounding fragment ions attributed to ammonia or water losses.  IRMPD of the 
underivatized peptide is very inefficient, resulting in no dissociation (spectrum not 
shown). Following the derivatization of this peptide with the PPITC reagent, IRMPD 
results exclusively in a complete series of y ions from yR1R to yR8R (Figure 3.2C). CID of the 
PPITC-peptide (Figure 3.2B) results in the formation of the yRn-1R as the most abundant 
sequence ion (i.e. yR8R), a finding similar to what has been previously reported for CID of 
SPITC-derivatized peptides.P46, 53, 54P CID of the modified peptide also results in the 
formation of the [M + CS + H]P+P which represents the partial loss of the PPITC reagent (- 
188 Da). This could serve as a derivatization marker since all modified peptides should 
yield a fragment resulting from the loss of 188 Da from the precursor ion and could 








Figure 3.2 ESI MS/MS mass spectra of protonated FSWGAEGQR, (A) CID of 
unmodified peptide (CID voltage 0.071 V, 30 msec), (B) CID of PPITC-
modified peptide (CID voltage 0.087V, 30 msec), (C) IRMPD of PPITC-
modified peptide (laser power 50 W, 20 msec). The [M + CS + H]P+P ion 
represents the partial loss of PPITC reagent. Magnification applies to all 
spectra over the mass range indicated. Water losses are represented by the 
pound sign and internal products by ○. 
The CID and IRMPD mass spectra obtained for a larger peptide, fibrinopeptide A 
(ADSGEGDFLAEGGGVR), are shown in Figure 3.3. The CID mass spectrum of the 
unmodified protonated peptide (Figure 3.3A) is dominated by two y ions (yR9R and yR14R) in 
addition to a few other y ions of low abundance, dehydrated y ions, and internal fragment 
ions of low abundance. This spectrum is unsatisfactory for de novo sequencing or manual 
interpretation, especially if the primary protein sequence of origin is unknown prior to 
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analysis. IRMPD of the unmodified protonated peptide again results in no dissociation 
(spectrum not shown), indicating that the peptide exhibits poor IR absorptivity and 
undergoes collisional deactivation more efficiently than energization. CID of the PPITC-
derivatized peptide results in the creation of different y ions than detected for the 
underivatized peptide (yR9R, yR11R, yR13R, yR14R, yR15R) but leaves the sequence of the entire C-
terminal side of the peptide inconclusive (Figure 3.3B). Moreover, gaps in the second 
half of the y series could lead to ambiguities in identifying the amino acid sequence or the 
incorrect assignment of residues. On the other hand, the IRMPD mass spectrum of the 
PPITC-derivatized peptide displays an extensive series of y ions ranging from yR2R to yR15R 
(Figure 3.3C), making sequence interpretation for this peptide straightforward. The high 
absorptivity of the derivatized peptide is reflected by the short irradiation time (10 msec) 
needed to obtain the IRMPD spectrum shown in Figure 3.3C. These short irradiation 
times would also provide a simple, quick test for determining derivatized peptides from 
unmodified peptides because only derivatized peptides will show any fragmentation with 







Figure 3.3 ESI MS/MS of protonated Fibrinopeptide A; (A) CID of unmodified 
peptide (CID voltage 0.11 V, 30 msec), (B) CID of PPITC-modified 
peptide (CID voltage 0.13 V, 30 msec), (C) IRMPD of PPITC-modified 
peptide (laser power 50 W, 10 msec). The [M + CS + H]P+P ion represents 
the partial loss of PPITC reagent. Water losses are represented by # and 
internal fragments by ○. Magnification applies to all spectra over mass 
range indicated. 
 
As shown by Muddiman et al.,P49-51P phosphorylation greatly increases IR 
absorptivities of peptides and this finding is consistent with our results for the PPITC-
derivatized peptides. To further probe the relative absorptivities of PITC-derivatized 
peptides, we examined the IRMPD mass spectra of peptides modified by PITC, SPITC, 
and PPITC.  Representative results are shown in Figure 3.3 for one peptide, 









































































msec of irradiation at 10.6 µm (Figure 3.4A), similar to what was observed for non-
derivatized peptides and giving a clear indication of the poor absorptivity of the PITC-
peptides. IRMPD of the SPITC-peptide results in the dominant production of the yRn-1R ion 
(in this case yR8R) after 25 msec of irradiation (Figure 3.4B). In contrast, the entire series of 
y ions is observed in the IRMPD mass spectrum of the corresponding PPITC-peptide 
after 20 msec (Figure 3.4C). Both the SPITC- and PPITC-derivatized peptides appear to 
have comparable absorptivities, but the PPITC-peptide yields a more complete series of y 
ions.   
 
Figure 3.4 IRMPD of protonated derivatized FSWGAEGQR; (A) PITC-peptide 
(laser power 50 W, 500 msec), (B) SPITC-modification (laser power 50 
W, 25 msec), (C) PPITC modification (laser power 50 W, 20 msec). The 
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CID and IRMPD mass spectra were acquired in triplicate for a series of eight 
PITC-, SPITC-, PPITC-derivatized peptides, as well as the underivatized peptides. The 
results are summarized in bar graph form in Figure 3.5 in terms of sequence coverage 
percentage, which is defined as the number of y sequence ions detected relative to the 
total number of possible y sequence ions (yR1R to yRn-1R), expressed as a percentage. For this 
comparison, a y ion is considered to be detected in a CID or IRMPD mass spectrum if it 
has a total peak area of 1% or greater. A value of 100% for the sequence coverage 
percentage means that every possible y ion (yR1R to yRn-1R) is detected. 
In most cases, the highest sequence coverage percentages were associated with 
the PPITC-derivatized peptides in conjunction with IRMPD, suggesting that IRMPD of 
the PPITC-peptides affords the optimal strategy for identification of peptide sequences.  
The main exception to this trend occurs for multiply charged ions (i.e. doubly protonated 
VIP and multiply protonated amyloid peptide (DAEFRHDSGYEVHHEK) (data not 
shown)). For the multiply protonated peptides, the extra mobile proton allows both a/b 
and y ions to remain charged in the MS/MS spectra and thus results in both a more 
elaborate array of potential a/b and y ions and overall lower abundance y ions amongst a 
more cluttered spectra. For YGGFLK, the sequence coverage percentage obtained upon 
CID of the unmodified peptide is comparable to that obtained upon IRMPD of the 
PPITC-derivatized peptide. However, the CID mass spectrum contains both b and y ions 
which complicates the spectral interpretation, whereas the IRMPD spectrum displays 













































































































































































































































































































3.4.3 Energy-Variable CID and IRMPD 
We previously found that the improvement in IRMPD efficiency afforded by the 
N-terminal sulfonation of peptides (using 2-sulfobenzoic acid) was due in part to a 
significant decrease in the critical energies of the peptides.P16P For the present study, the 
CID voltages and IRMPD irradiation times needed to cause dissociation of 50% of the 
parent ion population were determined and are summarized in Table 3.1 for one 
representative peptide, fibrinopeptide A. The required CID voltages do not change 
significantly for the unmodified, PITC-, SPITC-, and PPITC-derivatized peptides, 
suggesting that there is not a substantial change in the critical energies.  In contrast, there 
is a notable change in the IRMPD irradiation times for the same series of peptides, with 
the SPITC- and PPITC-derivatized peptides requiring less than 25 msec whereas the 
underivatized and PITC-derivatized peptides never reaching the 50% dissociation level 
even after 1000 msec of irradiation time. The results suggest that the SPITC- and PPITC-
derivatized peptides possess significantly amplified IR absorptivities which make them 
more amenable to IRMPD.  
 
Peptide IRMPD irradiation 
time (ms) 
CID voltage (V) 
Unmodified > 1000 0.104 
PITC > 1000 0.107 
SPITC 11.5 0.109 
PPITC 9.0 0.106 
 
Table 3.1  IRMPD irradiation times and CID voltages required to cause 50% 
dissociation of unmodified and modified-Fibrinopeptide A (protonated).  
All IRMPD irradiation values are ±1 ms and all CID values are ± 0.001 V 






It is also informative to consider the distributions of fragment ions obtained for 
the PPITC-derivatized peptides as a function of the CID voltage or IRMPD irradiation 
time. Monitoring the fragment ion distributions allows the genealogies of ions to be 
indirectly evaluated. Maps of the fragment ion distributions are shown in Figure 3.6 for 
one representative peptide, PPITC-derivatized fibrinopeptide A. The CID data (Figure 
3.6A) shows that all of the y ions evolve simultaneously, and their relative contributions 
do not change once the population of the protonated peptide is for the most part 
annihilated. The relative abundances of the various y ions continue to change as the 
irradiation time is increased for the IRMPD data (Figure 3.6B), even after the abundance 
of the parent ion is depleted. For example, the abundances of the yR4R and yR9R ions increase 
while the abundances of the yR14R and yR15R ions decrease at longer irradiation times. These 
complementary shifts in ion abundances support genealogical relationships between these 
sets of y ions, and this reflects the non-resonant nature of IRMPD that promotes 
conversion of primary fragment ions to secondary fragment ions, thus leading to the 













Figure 3.6 Energy-variable MS/MS distributions for y ions of protonated PPITC-
Fibrinopeptide A and the surviving protonated precursor: (A) energy-
variable CID and (B) time-variable IRMPD 
 
3.4.4 PPITC Derivatization and IRMPD of Tryptic Peptides 
The feasibility of the PPITC/IRMPD strategy was demonstrated for analysis of 
peptides obtained from the tryptic digestion of a protein, cytochrome c. The crude 
mixture of peptides obtained from enzymatic digestion of cytochrome c was derivatized 
with PPITC as described earlier, and then subjected to C18 clean-up prior to ESI-MS/MS 
analysis via direct infusion. A typical ESI mass spectrum of the PPITC-derivatized 








underivatized peptides and their corresponding PPITC-derivatized analogs based on the 
characteristic mass shift associated with the PPITC modification. IRMPD, with an 
average irradiation time of 50 msec at 50 W, and CID, with an average voltage of 0.58 V 
for 30 msec, were used to analyze the PPITC-derivatized peptides, and the sequence 
coverage percentages are summarized in Figure 3.8. The sequence coverage percentages 
obtained by IRMPD are consistently higher or at least comparable to the values obtained 
by CID, thus demonstrating the feasibility of applying the PPITC/IRMPD approach for 
proteomics. For example, upon CID the PPITC-derivatized tryptic peptide MIFAGIK 
produced the yR3R, yR4R, and yR5R ions whereas the yR2R, yR3R, yR4R, yR5R, and yR6R ions were obtained 
upon IRMPD. For the sole tryptic peptide with a C-terminal arginine, an even greater 
increase in coverage was obtained by IRMPD. Following CID, only the yR5R and yR6R ions 
were observed for the 1P+P charge state while the yR2R, yR3R, and the yR5R-yR10R were observed for 
the 2P+P charge state. In comparison, IRMPD of the 1P+P peptide yielded the yR2R through yR7R 
ions, as well as the yR9R and yR10R ions, and IRMPD of the 2P+P peptide generated the yR2R, yR3R, yR5R, 









Figure 3.7 PPITC derivatization of the tryptic digest of cytochrome C.  • = PPITC 
derivatized tryptic peptides, ◊ = unmodified tryptic peptides.  The arrows 
link the unmodified peptides with their PPTIC-derivatized counterparts.  
 
 
Figure 3.8 Sequence coverage percentages obtained by CID and IRMPD of 
unmodified and PPITC-modified tryptic peptides from cytochrome c, 
where the percent coverage is defined as the number of y sequence ions 
detected relative to the total number of possible y sequence ions (yR1R to yRn-
1R), expressed as a percentage.     
 

























































































































 In general, the overall improvement in the sequence coverage percentages 
obtained upon IRMPD in comparison to CID of the PPTIC-derivatized tryptic peptides is 
not as great as was seen for the individual model peptides summarized in Figure 3.5, and 
this is attributed to several reasons. First, the relative complexity of the tryptic digest 
mixture leads to lower yields of PPITC-modified tryptic peptides and corresponding 
lower CID and IRMPD sensitivities. Second, the formation of predominantly lysine-
terminated tryptic peptides in some cases leads to competitive formation of a/b ions that 
divides the ion current among a, b, and y ions and ultimately reduces the sensitivity of y 
ion detection. This result may be attributed to the lower gas-phase basicity of lysine in 
comparison to arginine.P55, 56P This difference in basicities of the terminal residues may 
change the proton mobility, thus altering the possibility of creating charged a/b ions in 
comparison with the y ions that stem from the sequestered N-terminal proton. The sole 
arginine-terminated peptide, TGPNLHGLFGR, in the 1P+P charge state shows the greatest 
improvement in sequence coverage percentage upon IRMPD, thus supporting that the 
increased basicity of the arginine terminus assists in sequestering the proton on the C-
terminus and thus eliminating the formation of charged a/b ions. However, despite the 
decreased basicity of lysine-terminated tryptic peptides, IRMPD analysis following 
PPITC modification still afforded the highest sequence coverage when compared to the 
other strategies (CID or using other derivatization reactions).  
 
3.5 CONCLUSIONS 
N-terminal derivatization using a novel phosphorylated phenylisothiocyanate 





novo sequencing of peptides. 4-Methylphosphonophenylisothiocyanate allows selective 
attachment of an IR chromophore to the peptides, thus enhancing their IR absorptivities 
and significantly reducing the irradiation times needed to cause efficient 
photodissociation. Extensive series of y ions are created upon IRMPD of the PPITC-
derivatized peptides, and the use of IRMPD allows detection of a greater array of the 
lower m/z y ions than possible with conventional CID. The PPITC/IRMPD strategy gives 
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Implementing Photodissociation in an Orbitrap Mass Spectrometer 
 
4.1 OVERVIEW 
A dual pressure linear ion trap Orbitrap was modified to permit infrared 
multiphoton dissociation (IRMPD) in the higher energy collisional dissociation (HCD) 
cell for high resolution analysis. A number of parameters, including the pressures of the 
C-trap and HCD cell, the RF amplitude applied to the C-trap, and the HCD DC offset, 
were evaluated to optimize IRMPD efficiency and maintain a high signal-to-noise ratio. 
IRMPD was utilized for characterization of phosphopeptides, supercharged peptides, and 
N-terminal modified peptides, as well as for top-down protein analysis.  The high 
resolution and high mass accuracy capabilities of the Orbitrap analyzer facilitated 
confident assignment of product ions arising from IRMPD. 
 
4.2 INTRODUCTION 
Over the past decade, both electron- and photon-based activation methods 
have emerged as versatile alternatives to collision-activated dissociation for 
fragmentation of peptides in proteomics applications.P1-5 PBoth infrared and ultraviolet 
photodissociation have proven successful tools for proteomic analysis using quadruple 
ion traps (QITs),P1P time-of-flight mass spectrometers,P6, 7P and Fourier transform ion 
cyclotron resonance (FT ICR) instruments;P8, 9P in the latter the high resolving power and 





Implementation of photodissociation on other high performance mass spectrometers is a 
compelling objective, especially with the growing adoption of Q-TOFP10P and OrbitrapP11, 12P 
type instruments for high throughput proteomics applications. Here we present the 
modification of an Orbitrap mass spectrometer to allow infrared multiphoton dissociation 
(IRMPD). We demonstrate a variety of applications that highlight the utility of IRMPD in 
combination with high resolution and mass accuracy Orbitrap mass analysis. 
 
4.3 EXPERIMENTAL 
4.3.1 Derivatization and Sample Preparation 
PPITC derivatized peptides were prepared using 20 µL of a 10 µg/µL solution of 
reagent solution buffered to a pH of 9.5 with 20 mM NaHCOR3R. It was incubated with 10 
µL of 1 mM peptide solution, 60 µL 100 mM NaHCOR3R (pH 8 – 9) and 70 µL water for 
30 minutes at 55º C.  The product was purified on a C18 spin column and diluted to 10 
µM prior to ESI analysis.  
Supercharged peptides were prepared by mixing peptides at 10 µM in 49.5/49.5/1 
methanol/water/acetic acid with 1% m-nitrobenzyl alcohol. 
 
4.3.2 Mass Spectrometry 
Samples were diluted to 10 μM in 49.5/49.5/1 water/methanol/acetic acid solution 
(v/v/v) and were run on a Thermo Scientific (San Jose, Ca) ETD-enabled LTQ Orbitrap 
XL that had been modified to allow entrance of a laser beam into the HCD cell as 
described below.  Samples were directly infused via pico tips (New Objective, Woburn, 






4.4 RESULTS AND DISCUSSION 
4.4.1 Optimization of parameters and instrumentation set-up 
  IRMPD was performed in the HCD cell of a modified hybrid mass spectrometer 




Figure 4.1 Schematic showing implementation of IRMPD in the HCD cell of a dual-
cell linear ion trap-orbitrap 
 
Typically utilized for beam-type CAD, the HCD cell provides a convenient region for 
photoexcitation of ions that have been mass-selected in the forward linear ion trap and 
transferred to the HCD cell.P13P Briefly, the HCD manifold was modified via the addition 
of a ZnSe window co-axial with the HCD cell and opening an aperture (d = ~2.54 mm) in 
its end plate electrode, allowing the irradiation of the HCD trapping region with IR 








Figure 4.2 Introduction of laser into HCD cell; laser directed into HCD manifold 
through addition of a ZnSe window concentric with the HCD cell and two 
mirrors mounted through the use of a toe clamp. 
 
Additionally, a nitrogen gas line was installed in the C-trap (a region normally used for 
spatial compression and temporally compact transfer of the ion bundle into the Orbitrap), 
and the top and bottom of the C-trap were fitted with ceramic plates to decrease gas 
conductance out of the C-trap, reducing the gas flow needed to achieve desired trapping 
efficiencies in the C-trap while minimizing the NR2R partial pressure in the QLT 
(quadrupole linear trap).  Taken as a whole, these modifications allowed substantially 
independent control of nitrogen gas flow to both the C-trap and HCD cell.  A 100 W 





the HCD cell as shown in Figure 4.2.  The beam width of the laser is 2.2 mm with a 
beam divergence of 7 mR.     
 The optimization of nitrogen flow to the HCD cell and C-trap is important for a 
number of reasons. IRMPD efficiency typically diminishes at higher pressures due to 
greater competition from collisional cooling.P14, 15P The trapping efficiencies of both the C-
trap and HCD cells are pressure-dependent; with improved trapping efficiencies 
occurring at higher pressures, particularly for high m/z ions. To evaluate the overall 
effects of gas flow (i.e., pressure) to both the HCD cell and C-trap on photodissociation 
efficiency, we evaluated three flow settings, one with reduced gas flow to both the C-trap 
and the HCD cell (P1), a second with a slightly increased flow to the C-trap while 
maintaining the reduced flow to the HCD cell (P2), and a third with no flow to the HCD 
cell and with the same increased flow to the C-trap as P2 (P3). Each flow setting led to 
corresponding changes in the pressures of the C-trap and HCD cell, and we observed 
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Figure 4.3 Effect of pressure on photodissociation efficiency and signal intensity. 
IRMPD of doubly charged phosphorylated peptide TSTEPQpYQPGENL, 
[M + 2H]P2+P, (10 µM in 49.5/49.5/1 methanol/water/acetic acid), following 
1 ms of 48 W irradiation at P1 (A), P2 (B), and P3 (C).  RF amplitude = 
1180 VRp-pR (corresponding to first m/z = 100), collision energy = -11 V.  
 
The P1 setting led to the lowest absolute signal levels, nearly one order of magnitude 
lower than those observed using the P2 setting, but with the highest photodissociation 
efficiency (i.e., conversion of precursor ions to product ions). For the P2 setting, the 
photodissociation efficiency was relatively low due to collisional cooling, but the 
absolute signal level for the precursor ion was the highest.  The P3 setting represented a 
compromise in the gas flow (and resulting pressures) that led to satisfactory precursor-to-
product conversion efficiency and best product ion sensitivity, and therefore was used for 
all subsequent experiments.   
In addition to pressure, the C-trap RF amplitude and HCD cell DC offset can 
influence overall IRMPD performance. As one parameter that defines the low-mass cut 
off, the C-trap RF amplitude is set as a function of the lower limit for the mass range 
selected through the user interface (also termed “first m/z”). The C-trap RF amplitude 
also influences the efficiency with which product ions are trapped prior to injection into 
the Orbitrap for mass analysis. Optimization of this parameter was needed in response to 
the pressure changes in the C-trap and HCD cell. As the C-trap RF amplitude varied from 
600-2300 VRp-pR (i.e., corresponding to a first m/z range of 50 – 200 Th), the signal-to-noise 
(S/N) ratio increased substantially until leveling off at RF amplitudes above 1800 VRp-pR 
(Figure 4.4). S/N was recorded for the most abundant fragment ion upon photoirradiation 
of a series of peptide precursor ions, and the averaged results are reported in Figure 4.4. 





while still maintaining a high S/N ratio, a C-trap RF amplitude of 1180 VRp-pR was used for 
most of the remaining experiments.  We varied the HCD cell RF amplitude from 100 – 
500 VRp-pR, but observed no significant changes in photodissociation efficiency (data not 
shown), suggesting that, over this range of RF amplitudes, the ion cloud maintains a 




Figure 4.4 Variation of S/N with C-trap RF amplitude. S/N was measured for the 
most abundant fragment ion arising from several different peptide 
precursor ions as the C-trap RF amplitude was varied. 
 
Additionally, the HCD cell DC offset, the potential difference between the C-trap 
and HCD cell, plays a significant role in IRMPD performance as a result of the reduced 
pressures in the HCD cell. The HCD cell DC offset determines the kinetic energy with 
which ions are transferred from the C-trap to the HCD region. Under normal instrument 


















CAD, with greater HCD cell DC offsets providing greater collisional activation. At the 
reduced HCD cell pressures needed for efficient IRMPD, trapping of ions in the HCD 
cell is less effective. The HCD cell DC offset is normalized relative to precursor mass; as 
a result, no single HCD cell DC offset was optimal for the transfer of precursor ions. For 
the mass range of precursor ions utilized in this IRMPD study, HCD cell DC offsets of -
8V to -11V relative to the QLT provided the best results in terms of the S/N ratio of 
isolated precursor (results not shown). For HCD cell DC offsets greater than -8V, the ions 
were not efficiently removed from the C-trap, and at offsets less than -11V, ions 
underwent collisional activation upon injection to the HCD cell. At HCD cell DC offsets 
of -8V to -11V, collisional activation prior to IRMPD was avoided while still efficiently 
extracting ions from the C-trap. 
 
4.4.2 Applications 
 After optimization of the parameters summarized above, we utilized 
IRMPD in the hybrid Orbitrap system for a number of applications. Although 
conventional peptide cations exhibit relatively low IRMPD efficiencies due to significant 
competition with collisional cooling, phosphopeptides display ample IRMPD efficiencies 
even at mTorr pressures due to the high photoabsorptivities of P-O bonds at 10.6 µm.P16, 17 
P hosphorylated peptides can be fully characterized and distinguished in a complex 
mixture with the phosphorylation site being easily pinpointed through IRMPD following 
short irradiation times.P18P As shown in Figure 4.3C, the phosphorylated peptide, 
TSTEPpYQPGENL, yielded an array of diagnostic sequence ions after just 1 ms of 
irradiation. Production of bR7R, bR8R, bR11 Rand yR9R sequence ions, all of which retained the 





to phosphorylated peptides, peptides specifically derivatized via attachment of an IR 
chromophore can likewise be dissociated with high efficiency. As we described 
previously, peptides can be derivatized at their N-terminus using a phosphono 
derivatization agent, PPITC, which adds a strong IR chromophore.P19P Upon IRMPD, 
PPITC derivatized peptides dissociated into b and y ions with preferential cleavage at the 





Figure 4.5 IRMPD of unmodified (A) MEHFRWG (2+) and (B) PPITC-derivatized 
MEHFRWG (2+) (10 µM in 49.5/49.5/1 methanol/water/acetic acid) 
following 10 ms of 48 W irradiation, C-trap rf amplitude = 1180 VRp-pR, 
(corresponding to first m/z = 100), collision energy = -11V, * = neutral 
losses such as HR2RO and NHR3, R  = precursor, [M + CS + 2H]P2+P represents 
the ion arising after partial loss of the derivatization reagent. 
 
Ions in higher charge states undergo photodissociation more efficiently than those 
in lower charge states,P20 Pan outcome largely attributed to the greater number of mobile 


































protons in highly charged peptide ions. The abundances of ions in higher charge states 
can be enhanced via a “supercharging” method in which a small amount of a solvent 
additive, like m-nitrobenzyl alcohol, alters the charging dynamics of ESI droplets and the 
resulting ions.P21, 22P This supercharging method also proved to be beneficial for improving 
the IRMPD efficiencies, as illustrated in Figure 4.3 for supercharged peptide, 




Figure 4.6 MS/MS of supercharged fibrinopeptide A (3+, sequence 
ADSGEGDFLAEGGGVR, 10 µM in 49.5/49.5/1 methanol/water/acetic 
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acid with 1% m-nitrobenzyl alcohol) (A) IRMPD using 8 ms of 48 W 
irradiation.  * = neutral losses such as HR2RO and NHR3R, C-trap RF amplitude 
= 1180 VRp-pR (corresponding to first m/z = 100), collision energy = -11V, 
and (B) HCD DC offset ~ -18 V and C-trap rf amplitude = 870 VRp-pR 
(corresponding to first m/z = 75). 
 
A large array of b and y ions was generated after 8 ms of irradiation. The expected 
masses of the bR3R ion, 274.1042 Da, and yR2R ion, 274.1882 Da, (a difference of 306 ppm 
from each other and 2.9 ppm from the experimental values) make them indistinguishable 
in lower resolution ion traps. IRMPD in the HCD cell with subsequent mass analysis in 
the Orbitrap allowed unambiguous assignment of these ions.  In some but not all cases 
IRMPD results in a greater array of fragment ions than observed upon HCD, presumably 
due to consecutive IRMPD of primary fragment ions.   
The enhanced resolution and mass accuracy is particularly beneficial for 
assignment of sequence ions upon IRMPD of whole proteins. Figure 4.7 shows the 
IRMPD spectrum of the 12+ charge state of ubiquitin in which many of the fragment ions 
are highly charged, ranging from a singly charged bR2R ion to the multi-charged yR70RP11+P ion. 
With the increased resolution afforded by Orbitrap mass analysis, all photodissociation 
product ions were confidently distinguished and assigned. For example, in the inset of 







Figure 4.7 IRMPD of the 12+ charged state of ubiquitin (10 µM in 49.5/49.5/1 
methanol/water/acetic acid) following 25 ms of 48 W irradiation, C-trap 
RF amplitude = 2300VRp-pR (corresponding to first m/z = 200), collision 
energy = -11V. Inset shows baseline resolution of the yR58RP10+P ion with a 
mass accuracy of 3.5 ppm relative to the theoretical m/z of 653.7562.    
 
Interestingly, IRMPD also resulted in a greater degree of backbone cleavage 
selectivity compared to that obtained upon HCD with particular enhancement N-terminal 
to proline and C-terminal to glutamic acid residues. This phenomenon has been noted 
previously upon application of IRMPD in a dual pressure linear ion trap,P23P albeit without 
high resolution or high mass accuracy ion assignments.  A comparison of cleavage 
selectivity obtained upon IRMPD versus HCD for the 10+, 11+, and 12+ charge states of 
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Figure 4.8 Summed b and y abundances for complementary ion pairs as a function of 
residue number from resulting cleavages of ubiquitin with IRMPD for (A) 









































































































































































[M + 10H]P10+P, (B) [M + 11H]P11+P, and (C) [M+12H]P12+P; and with HCD for 
the (D) [M + 10H]P10+P, (E) [M + 11H]P11+P, and (F) [M+12H]P12+ Pions. 
 
4.5 CONCLUSIONS 
The results summarized here illustrate the practical rewards of photodissociation 
in an Orbitrap hybrid mass spectrometer, providing high resolution analysis on a variety 
of samples. Photodissociation was accomplished in the HCD cell in which a decrease in 
its gas flow (and pressure), along with a concomitant increase in the gas flow to the C-
trap, most effectively balanced IRMPD efficiency and overall ion abundance (S/N). 
IRMPD does not out-perform HCD, but it promotes an equally or more diverse array of 
fragment ions in some cases and demonstrates significantly enhanced performance for 
ions containing suitable chromophores.  Maximizing both photodissociation and 
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Enhancement of Ultraviolet Photodissociation Efficiencies through 
Attachment of Aromatic Chromophores  
 
5.1 OVERVIEW 
Two N-terminal derivatization reagents containing aromatic chromophores, 4-
sulfophenyl isothiocyanate (SPITC) and 4-methylphosphonophenyl isothiocyanate 
(PPITC), were used to increase the dissociation efficiencies of peptides upon ultraviolet 
photodissociation (UVPD) at 193 nm. The resulting UVPD spectra are dominated by C-
terminal ions, including y, z, x, v, and w ions, and immonium ions. The attachment of the 
PPITC or SPITC groups leads to a reduction in the number and abundances of N-terminal 
ions because the added phosphonate or sulfonate functionalities result in neutralization of 
some of the N-terminal species, ones that might normally be singly protonated in the 
absence of the negatively charged sulfonate or phosphonate groups. In addition, the 
greater photoabsorptivities of the PPITC- and SPITC-derivatized N-terminal product ions 
enhanced their secondary photodissociation, leading to formation of immonium ions.   
 
5.2 INTRODUCTION 
The ability to address increasingly complex questions in proteomics has 
motivated the development and application of a variety of new tandem mass 
spectrometric strategies over the past decade. Although collision induced dissociationP1P 
remains the most popular activation method, electron-based methods, including electron 





(photodissociation)P5-7P have gained recognition as promising alternatives. In particular, 
photodissociation affords fast, tunable energy deposition based on the wavelength used 
and the irradiation time. Ultraviolet photodissociation has proven well-suited for 
proteomic applications due to the high UV photoabsorptivity of peptide amide bonds.P8P 
Irradiation with high energy UV photons promotes a collection of high energy fragments, 
primarily a, x and side chain loss (d, v, and w) ions in time-of-flight mass spectrometers 
while b and y fragments also remain abundant in ion trap instruments.P9P In addition, 
UVPD can be implemented on the nanosecond to microsecond timescale by using fast 
pulsed lasers, providing incentive for its adaptation to high throughput applications. It has 
been noted that some amino acid side chains, specifically the aromatic residues,P10-12P play 
a more important role in the absorption of UV radiation. It was reported that upon UVPD 
at 266 nm the tryptophan (W), tyrosine (Y), or phenylalanine (F) residues in a peptide led 
to a chromophore effect in which cleavage near the aromatic residue was increased and 
lower irradiation times were needed to significantly deplete the parent ion population. 
These previous studies showcased the impact of specific chromogenic functionalities on 
UVPD behavior and motivated our interest in exploiting this factor for enhancing UVPD 
efficiencies in proteomic applications via derivatization of peptides to incorporate 
aromatic moieties.  
There have been a number of derivatization strategies implemented for proteomic 
applications, including those designed to alter the fragmentation patterns of peptidesP13-16P 
and others developed to attach specific chromophores.P17-23 PFor example, N-terminal 
sulfonation has proven to be a useful tactic for enhancing de novo sequencing of peptides 





negatively charged group at the N-terminus of a peptide, all singly charged N-terminal 
fragments are neutralized which suppresses the presence of b-type or other N-terminal 
fragment ions in the resulting MS/MS spectra. This progression towards enhancement of 
a single ion type, more specifically the C-terminal ions in this case, facilitated the 
interpretation of MS/MS product ion spectra using de novo sequencing methods. A 
variation of this method utilized 4-methylphosphonophenylisothiocyanate (PPITC) to 
attach an IR-chromogenic phosphonite group to the N-terminus of peptides which 
increased their IRMPD efficiencies and improved their individual sequence coverage.P17P 
This type of derivatization strategy was also incorporated into a UVPD method in which 
UV chromophores were attached at the N-termini of peptides via an AlexaFluor 
sulfonation reagent, endowing the peptides with high photoabsorptivity at 355 nm and 
simplifying the resulting spectra to a single series of y ions.P20P As another example of an 
innovative derivatization method, Julian and coworkers has pursued site-selective 
dissociation of peptides upon UVPD at 266 nm by modification of cysteine residues with 
quinone moieties. The integrated cysteine modification/UVPD method resulted in 
backbone cleavage at the modified cysteine site.P22P These prior studies have demonstrated 
the ability to enhance and/or tune the dissociation properties of molecules based on 
incorporation of specific chromophores, an approach that we extend in the present work.  
In this study, two N-terminal derivatization reagents, 4-sulfophenyl isothiocyanate 
(SPITC) and 4-methylphosphonophenyl isothiocyanate (PPITC),P17P were utilized to 
increase the dissociation efficiencies of peptides upon UVPD at 193 nm via attachment of 
aromatic groups that serve as UV chromophores (see Figure 5.1). The activation and 





compared to that of the underivatized peptides to demonstrate the enhanced UVPD upon 
addition of simple aromatic chromophores. Moreover, the ionizable PPITC and SPITC 
functional groups reduce the number and abundances of N-terminal ions for both singly 
and multiply charged precursor ions, and thus the resulting UVPD spectra are heavily 
dominated by C-terminal ions including y, z, x, v, and w ions, as well as immonium ions. 
This N-terminal derivatization/UVPD strategy allows confident identification of the 
entire peptide sequence including the N-terminal residue due to the formation of 




Figure 5.1 Structures of N-terminal derivatization reagents (shown as deprotonated 
forms); mass shifts associated with each are indicated in parenthesis.   
 
5.3 EXPERIMENTAL 
5.3.1 Materials and Reagents 
All chemicals were purchased from Sigma Aldrich (St. Louis, MO) except for the 
following peptides which were obtained from BACHEM (King of Prussia, PA): 
FSWGAEGQR, DRVYIHPFHL, DAEFRHDSGYQVHHQK, ASHLGLAR, 
YRPPGFSPFR, GNHWAVGHLM, MEHFRWG, and RQpSVELHSPQSLPR.  























5.3.2 Derivatization and Sample Preparation 
For all model peptides, 20 μL of a 10 μg/ μL reagent solution buffered to pH 8.5 
with 20 mM NaHCOR3R was incubated with 10 μL of 1 mM peptide solution for 30 
minutes at 55 PoPC. For bovine serum albumin (BSA), the protein was reduced by mixing 
11 μL of 150 mM dithiothreitol with 40 μL of 1 mM BSA for 45 minutes at 55 PoPC, 
followed immediately by alkylation with the addition of 12 μL of 550 mM iodoacetamide 
(IAM) buffered to a pH of ~8.0 with NHR3RHCOR3R) and reacting for 30 minutes in the dark 
at room temperature. The protein was diluted with 100 mM NHR4RHCOR3R and digested with 
1 mg/mL trypsin in 1 mM HCl in a 1:100 w/w ratio overnight at 37 PoPC. The reduced and 
alkylated protein was then desalted using a C18 spin column and reacted with each 
reagent as described above. Reactions were all terminated with a small addition of 1.5 μL 
5% trifluoroacetic acid followed by desalting on a C18 spin column. The eluent was 
diluted to 10 μM before ESI analysis with 49.5/49.5/1 HR2RO/MeOH/Acetic Acid.   
 
5.3.3 Mass Spectrometry and Liquid Chromatography 
All experiments were performed on a ThermoFinnigan LTQ XL linear ion trap 
mass spectrometer (ThermoFinnigan, San Jose, CA) equipped with a standard ESI 
source. The LTQ mass spectrometer was modified for UVPD as described earlierP24P with 
a CaFR2R optical window to allow introduction of photons from a Coherent ExciStar XS 
laser operated at 193 nm (Coherent Lambda Physik, Germany). The laser was directed 
through a 1.7 mm entrance aperture that was in line with the 2 mm aperture of the exit 





Solutions were directly infused at a flow rate of 3 μL/min at a concentration of 10 μM in 
49.5:49.5:1 MeOH:HR2RO:Acetic acid. An ESI voltage of 4 kV and a heated capillary 
temperature of 180PoP C was used for all mass spectrometry experiments. All UVPD 
experiments were performed using a qRzR value of 0.1 with the total activation period 
ranging from 0.03 msec (the minimum default activation period for a single 5 ns laser 
pulse using Thermo Excalibur instrument software) to 10 msec (sufficient for 5 laser 




      



















Liquid chromatography was performed using a Dionex UltiMate 3000 system 
(Sunnyvale, CA). An Agilent ZORBAX 300SB-CR18R column (Santa Clara, CA) (150 × 0.3 
mm, 5 µm particle size) was used for all separations. The column temperature was kept 
constant throughout the run at 40°C. Eluent A consisted of 0.1% formic acid in water and 
eluent B 0.1% formic acid in acetonitrile. A linear gradient from 5% eluent B to 40% 
eluent B over 65 min at 5 µL/min was used. Injections of approximately 1 µg (20 
picomoles) were used for the digested BSA sample. For all LC-MS/MS runs, the first event 
was the full mass scan (m/z range of 400 – 2000) followed by ten consecutive MS/MS 
(either UVPD or CID) events on the ten most abundant ions from the full mass scan. A q-
value of 0.1 and one, 5 ns UV pulse applied per MS/MS scan was used for UVPD 
activation, while a q-value of 0.25, an activation time of 30 ms, and a normalized collision 





was set to 100 ms, and each centroid mass spectrum and tandem mass spectrum was the 
average of three microscans. For all LC-UVPD experiments a background subtraction was 
also utilized due to a high abundance of photoionization products seen around and below 
m/z 200. These ions have been hypothesized to be the products of photoionization of 
organics species that reside in the vacuum system.P25P Background spectra were collected in 
the centroid mode while no sample was being infused so that no ions were being trapped 
and using an isolation window of m/z 500 ± 4. The average of 20 scans was then subtracted 
from the LC-UVPD .RAW file using the Thermo Fisher Xcalibur version 2.0.7 software. 
 
5.4 RESULTS AND DISCUSSION 
5.4.1 UVPD of Model Peptides 
 UV photodissociation has many attributes that make it extremely appealing for 
proteomic applications, including its ability to produce a variety of sequence ions 
(depending on the wavelength) using very short activation times.P5, 7P  The large array of 
sequence ion types make the resulting UVPD spectra amenable to database search 
algorithms, as demonstrated in our recent investigation of the applicability of UVPD for 
identification of proteins from a human cell lysate using an activation of a single 5 ns 
pulse of 193 nm irradiation.P26P  However, we noticed that the UV photodissociation 
efficiencies were lower for tryptic peptides that did not possess any aromatic residues, in 
some cases hampering sequence identification.  In fact, aromatic residues have been 
shown to greatly increase the absorptivity of peptides at 266 nm.P10-12P We sought to 
uniformly increase the photodissociation efficiencies of peptides at 193 nm by attaching 





N-terminal derivatization schemes and demonstrated that in combination with IRMPDP17P 
or ETDP27P these reactions substantially improved the de novo sequencing of peptides, 
primarily by eliminating the redundant b or c ion series that impede differentiation of the 
b and y ions or c and z ions.   Here the same N-terminal derivatization reagents, SPITC 
and PPITC, are used to modify a series of peptides to specifically enhance their 
absorptivities and consequently their photodissociation efficiencies at 193 nm via the 
incorporation of aromatic chromophores.  Although the SPITC and PPITC reagents have 
similar UV chromophores, the acidities of the sulfonate and phosphonate substituents are 
sufficiently different to warrant examination of both of these derivatization reagents and 
their impact on the formation and survival of diagnostic sequence ions in the present 
UVPD strategy.   A third peptide derivatization agent, phenylisothiocyanate (PITC), was 
also considered because it appends the same aromatic chromophore.  However, the rather 
low peptide derivatization efficiency of PITC compared to SPITC and PPITC renders it 








Figure 5.2 UVPD comparison of (A) underivatized, (B) SPITC-derivatized and (C) 
PPITC-derivatized ASHLGLAR (2+) after a single 8 mJ pulse of 193 nm 
irradiation. * represents internal ions, ■ = retains SPITC modification, ∆ = 
retains PPITC modification,  represents the remaining precursor ion. 
 
Examples of the resulting UVPD spectra are shown above in Figure 5.2 for the 
doubly protonated peptide ASHLGLAR. This peptide has no aromatic side-chains in its 
amino acid sequence, and in its unmodified form displays a moderately low degree of 
dissociation, giving a photodissociation efficiency of ~30% after a single pulse of UV 
irradiation. An array of sequence ion types are produced, including a, b, z, y, and 
immonium ions, but the net sequence coverage is incomplete based on using a fragment 
ion abundance threshold of 0.5% relative to the precursor abundance. In addition, all of 
the fragment ions arising from backbone cleavages have rather low abundances, thus 
limiting the ability to correctly identify the peptide using standard algorithms and also 
reducing the overall sensitivity of the method. After derivatization using either the SPITC 
v3
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or PPITC reagent, a single pulse of UV irradiation was sufficient to produce abundant 
sequence ions (Figure 5.2B and 5.2C, respectively). Of particular high abundance is the 
yR(n-1)R peak that represents the Edman degradation type cleavage that is commonly seen 
after N-terminal PITC-type derivatization in which the N-terminal amino acid is most 
readily cleaved.P15, 17, 27, 28P This cleavage near the chromophore arises from a 
fragmentation pathway facilitated by the PITC moiety and is observed upon CID or 
UVPD. An array of other sequence ions, including a, b, x, y, z, and immonium ions are 
also produced. The bR1R product ion is highly abundant despite the fact that it contains the 
aromatic group with its associated sulfonate or phosphonate moiety, indicating that the 
latter must remain protonated in the bR1R product ions.   
The photodissociation efficiencies (as defined in equation 1 in the experimental 
section) were measured for a series of peptides to evaluate the impact of the aromatic 
chromophores. As summarized in Figure 5.3, the non-derivatized peptides exhibit 
photodissociation efficiencies ranging from 28% to 66% (average is 50%), with the 
efficiencies generally increasing for those peptides with one or more amino acids 
containing aromatic side-chains. In comparison, the photodissociation efficiencies range 
from 50% to 95% for the SPITC- and PPITC-derivatized peptides, with the efficiency 








Figure 5.3 Photodissociation efficiencies obtained for UVPD of non-derivatized and 
N-terminally derivatized peptides after a single 8 mJ pulse of 193 nm 
irradiation. 
 
In addition, the two PITC reagents offer the added benefit of simplifying the 
UVPD spectra through the neutralization of many N-terminal fragments due to the 
presence of the ionizable phosphonate or sulfonate groups. The distribution of C-terminal 
(v, w, x, y and z) and N-terminal (a and b) product ions was examined for a series of eight 
peptides both in their unmodified and PPITC- or SPITC-derivatized forms, and the 







Figure 5.4 Distribution of C-and N-terminal Ions Produced by UVPD (single pulse,  
193 nm) of Peptides.Pa 
P
a
P The m/z value of the singly-charged PPITC-ADSGEGDFLAEGGGVR1 falls 
above the m/z range of the mass spectrometer and thus could not be analyzed.   
An “x” indicates when a charge state was not present for a specific peptide, thus 
preventing data acquisition. 
 
The portion of N-terminal ions is uniformly lower for the PITC-derivatized peptides than 
for the unmodified peptides, with the difference being particularly striking for a few of 




























N-terminal fragment ions is more notable for the singly charged PITC-modified peptides 
because of the lower probability that the N-terminal portion of the peptide will end up 
sequestering two protons (one localized at the ionizable PITC group and one at the amine 
terminus) to maintain a net charge of 1+. The singly charged PITC-peptides yielded the 
most simplified MS/MS spectra that could be utilized in de novo sequencing applications 
which exploit specific series of ions for prediction of peptide sequences. With respect to 
the UVPD spectra of the PITC-derivatized peptides, the formation of w and v (C-
terminal) ions is likewise advantageous because these side-chain loss fragment ions allow 
distinction between isobaric amino acid residues such as isoleucine and leucine that pose 
particular challenges for identification by conventional activation methods like CID. 
Figure 5.2 shows an example of this additional benefit upon inspection of the w and v 
ions. In Figure 5.2A, the vR3R ion confirms that the third amino acid from the C-terminus is 
Leu; however, with only a yR5R ion available to identify the fifth amino acid from the C-
terminus, differentiation between Leu and Ile is not possible. In contrast, in both Figure 
5.2B and 5.2C the presence of the wR5R ion allows unambiguous identification of the fifth 
amino acid as Leu based on the side chain loss.        
Interestingly, the multiply charged peptide ions also showed a significant shift in 
the distribution of C-terminal versus N-terminal ions upon derivatization as seen in 
Figure 5.4. The enhancement of C-terminal ions and neutralization of N-terminal ions 
(due to the presence of the ionizable chromophore) would be expected to be most 
pronounced for singly charged precursors which have a limited number of mobile 
protons. The continuation of the significant preference for C-terminal ions for the 





terminal Edman degradation type yR(n-1)R ions remain dominant products even for the multi-
charged peptides (as demonstrated also upon CID of the PITC-derivatized peptides, data 
not shown). Second, even for CID or UVPD of multi-charged peptides, many of the 
fragments are singly charged, suggesting that net neutralization of N-terminal products 
containing an ionizable group remains probable. Moreover, it is well known that product 
ions can absorb one or more additional photons and undergo further fragmentation (i.e. 
secondary dissociation). We have demonstrated this concept with UVPD at 355 nm 
utilizing the N-terminal derivatization chromophore, AlexaFluor 350 in which the 
chromophore-containing N-terminal ions absorbed additional photons and dissociated.P20P 
In contrast, the C-terminal ions did not contain UV chromophores and remained as stable 
product ions, thus resulting in MS/MS spectra dominated by C-terminal ions.P20P We 
speculate that the N-terminal products ions formed upon UVPD in the present study, all 
which contain the attached SPITC or PPITC aromatic chromophore, have high UV 
absorption efficiencies that lead to their efficient secondary photodissociation. Although 
the data summarized in Figure 5.5 was collected using only a single laser pulse, it is 
conceivable that first generation product ions may absorb a second photon during the first 
UV pulse and dissociate into non-detectable products. This process would eliminate or 








Figure 5.5 Total number of fragment ions produced for a tryptic digest of BSA after a 
single 8 mJ pulse at 193 nm.Pa 
P
a
PSome of the SPITC-peptides did not show up in any of the LC runs and 
thus could not be included.    












































 The most abundant N-terminal ions for the SPITC and PPITC-peptides upon 
UVPD are the bR1R and aR1R ions, as noted earlier. Although the relative abundances of the C-
terminal ions increased in comparison to the N-terminal ions with the number of pulses, 
in general the dominant product ions became the immonium ions, thus confirming that 
both the N-terminal and C-terminal sequence ions dissociate into simple immonium ions. 
This secondary fragmentation into predominant immonium ions also occurred for the 
underivatized peptides as well and demonstrates the fact that multiple pulses of 
irradiation may not be an effective option for increasing the portion of backbone 
fragments (i.e. N-terminal and C-terminal sequence ions) produced upon UV 
photodissociation. In all cases, the greatest relative abundances of sequence ions were 
generated with a single pulse of irradiation. Phenylisothiocyanate (PITC) was also 
evaluated as a UV chromophore. While PITC-derivatized peptides yielded similar UVPD 
results as those derivatized by SPITC or PPITC, the poor peptide reaction efficiency (20-
40%) compared to the other two (50-90%) rendered it less promising for protein 
applications. 
 
5.4.2 UVPD of BSA Tryptic Digest 
The same derivatization reactions were applied to a tryptic digest of BSA in order 
to evaluate the level of improvement in UVPD efficiencies for a more complex mixture. 
For this assessment, bovine serum albumin was reduced, alkylated and digested, divided 
into three aliquots with one unmodified and the other two subjected to SPITC or PPITC 
derivatization, then analyzed by LC-UVPD-MS. As shown in Figure 5.6, the number of 





of UV irradiation is summarized for all peptides identified. Although the total number of 
diagnostic ions remains similar for the PITC-derivatized and non-derivatized tryptic 
peptides, the impact on sequence coverage and peptide identification is rather substantial 
because of the change in the distribution of N-terminal and C-terminal ions, as described 
earlier for the model peptides.  
 
 












































Figure 5.6 Total number of fragment ions produced for a tryptic digest of BSA after  
a single 8 mJ pulse at 193 nm.Pa 
P
a
PSome of the SPITC-peptides did not show up in any of the LC runs and 
thus could not be included. 
For the PITC-derivatized peptides, the number of N-terminal (a, b, c) ions decreases 
whereas the number of C-terminal (x, y, z, v, w) ions correspondingly increases. 
Moreover, the photodissociation efficiencies are greater for the PITC-derivatized peptides 
(see Figure 5.7), especially ones that are produced in 1+ or 2+ charge states. The impact 
of an additional aromatic group is especially noticeable for the tryptic peptides containing 
zero to one aromatic amino acid. The increase in dissociation efficiency leads to more 
abundant fragment ions which increase the overall sensitivity of the method. This 
improvement in dissociation efficiency is beneficial when utilizing database search 
algorithms in which the abundances of key sequence ions must occur above a certain 










Figure 5.7 UV photodissociation efficiencies of tryptic BSA peptides after a single 8 
mJ pulse at 193 nm.PbP   
P
b
PThe  designates those peptides with a single or no aromatic amino 
acids and that generate predominantly ions in the 1+ to 2+ charge state.   
Some of the SPITC-peptides did not show up in any of the LC runs which 














































The bar graphs in Figure 5.8 display the relative distributions of N-terminal and 
C-terminal products ions for the PITC-modified peptides compared to the analogous 
alkylated peptides (IAM-alkylated). The abundances of all of the C-terminal or N-
terminal sequence ions were summed and used to create product ion distribution maps, 
with the exclusion of the N-terminalR RbR1R and aR1R ions whose abundances were exaggerated 
due to the preferential cleavage of the N-terminal amino acid for the PITC-peptides. The 
alkyated but non-chromophore-containing IAM-peptides show a higher abundance of N-
terminal ions, averaging 37%, whereas the SPITC- and PPITC-peptides averaged 11% N-
terminal ions and 89% C-terminal ions. For the SPITC- and PPITC-peptides, the aR1R and 
bR1R ions actually constitute the largest percentage of N-terminal ions upon UVPD of 
peptides in charge states greater than one, while most of the other N-terminal ions are 
much lower in abundance if present at all. The IAM-peptides produced fewer C-terminal 







Figure 5.8 N-terminal and C-terminal product ion distributions for BSA tryptic 
peptides based on the type of derivatization method, following a single 8 
mJ pulse of UV irradiation in which the relative portion of N-terminal (red 
bars) and C-terminal (white bars) sequence ions is calculated by (Σ 
Abundance of all N or C Terminal IonsPcP)/(Σ Abundances of all C and N 
ions).   
P
c
PFor the N-terminal data, all N-terminal ions are included except the bR1R 
and aR1R ions.   Some of the SPITC-peptides did not show up in any of the 
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Two N-terminal peptide derivatization reagents containing aromatic 
chromophores were utilized to enhance photodissociation of peptides at 193 nm. The 
attachment of aromatic groups increased the photodissociation efficiencies by up to a 
factor of two and resulted in production of a slightly greater number of diagnostic 
fragment ions. While the overall increase in the number of sequence ions was not 
dramatic, there was a significant increase in the number and abundances of C-terminal 
ions and corresponding decrease in the number and abundances of N-terminal ions. The 
number and abundances of N-terminal ions were reduced due to two factors. The 
presence of the ionizable PPITC or SPITC functionalities resulted in neutralization of 
some of the N-terminal species (ones that might normally be singly protonated without 
the negatively charged sulfonate or phosphonate group). Moreover, the higher 
photoabsorptivities of the N-terminal PITC-modified product ions enhanced their 
secondary dissociation upon absorption of additional photons, resulting in fragmentation 
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Enhanced Electron Transfer Dissociation through Fixed Charge 
Derivatization of Cysteines  
 
6.1 OVERVIEW 
Electron transfer dissociation (ETD) has proven to be a promising new ion 
activation method for proteomics applications due to its ability to generate c- and z-type 
fragment ions in comparison to the y- and b-type ions produced upon the more 
conventional collisional activation of peptides. However, low precursor charge states 
hinder the success of electron-based activation methods due to competition from non-
dissociative charge reduction and incomplete sequence coverage. In the present report the 
reduction and alkylation of disulfide bonds prior to ETD analysis is evaluated by 
comparison of three derivatization reagents: iodoacetamide (IAM), N,N-dimethyl-2-
chloro-ethylamine (DML), and (3-acrylamidopropyl)-trimethyl ammonium chloride 
(APTA). While both the DML and APTA modifications lead to an increase in the charge 
states of peptides, the APTA-peptides provided the most significant improvement in 
percent fragmentation and sequence coverage for all peptides upon ETD, including 
formation of diagnostic ions that allow characterization of both the C- and N-termini. In 
addition, the formation of product ions in multiple charge states upon ETD is minimized 







There have been tremendous inroads in methodologies for the activation and 
dissociation of ions for proteomics applications in recent years. Although collision 
induced dissociation (CID) remains one of the most popular activation methods, largely 
due to a well-developed understanding of peptide fragmentation patterns,P1-3P other 
methods that address some of the more challenging sequencing problems have gained 
momentum. For example, due to its tunable and well-defined energy deposition, surface 
induced dissociation has proven to be very effective for peptide fragmentation, as well as 
more recently for examination of protein macromolecular complexes.P4P Photodissociation 
has also emerged as a promising alternative ion activation method for biological 
molecules, offering efficient energization of ions via a collision-free photoabsorption 
process.P5, 6P Most recently, the development of electron-based dissociation methods, 
including electron capture dissociation (ECD)P7, 8P and electron transfer dissociation 
(ETD),P9, 10P has further expanded the suite of ion activation strategies used for proteomic 
applications.  
The electron-based activation methods entail reactions of low energy electrons 
(ECD) or radical anions (ETD) with multiply charged peptides or proteins, leading to 
preferential cleavages of the N-CRαR bonds along the backbone that result in the production 
of complementary c- and zP•P-type ions. The peptide length and amino acid composition 
have shown little influence on the fragmentation patterns of these dissociation methods in 
large scale studiesP11P although two more detailed targeted studies have reported some 





identification of post-translational modifications of proteins as these labile modifications 
are retained on the amino acid side chains during ion activation and dissociation, and thus 
can be readily tracked, whereas they are often lost with other ion activation methods. 
Despite their tremendous promise, the electron-based dissociation methods exhibit a 
significant charge state dependence reflected by the fact that ions in lower charge states 
tend to undergo charge reduction without subsequent dissociation into informative c and 
zP•P sequence ions.P8, 14, 15P The use of trypsin as a standard enzymatic reagent to cleave 
proteins prior to MS/MS analysis has in some ways exacerbated the tendency for charge 
reduction upon ECD or ETD because the large natural abundance of lysine and arginine 
residues in proteins results in the production of relatively short peptides upon tryptic 
digestion that yield lower charge states upon ESI. 
Several methods have been aimed at alleviating this charge-state dependence of 
ETD and ECD, either utilizing auxiliary energization of ions to convert them to more 
meaningful sequence ionsP14-20P or by increasing the charge states of the precursor ions 
prior to activation.P16-19P The former has been achieved by implementing supplemental 
collisional activation of the charge-reduced non-dissociated precursor ions or by 
irradiating the precursor ions with photons to disrupt the noncovalent bonds formed 
between c- and zP•P-type product ion pairs.P14-20P Elevating the temperature of the ions in an 
ICR cell via blackbody heating provided sufficient energy to the precursor ions to destroy 
the noncovalent bonding and increase the formation of c- and zP•P-type fragment ions upon 
ECD.P20, 21P In a process termed activated ion-ECD (AI-ECD) by McLafferty et al., 
simultaneous collisional activation and electron irradiation (i.e., ECD) of precursor ions 





charge reduction of precursor ions.P22, 23P Both the Coon and McLuckey groups have 
employed supplemental collisional activation of charge-reduced products from electron 
transfer dissociation reactions, improving peptide sequence coverage.P11, 24, 25P More 
recently, the Coon group implemented photoirradiation during ETD of peptides in a  
linear ion trap mass spectrometer in a method analogous to AI-ECD described above.P26P 
This method significantly improved the sequence coverage of peptides having higher 
precursor m/z values (i.e. lower charge states).   
Another approach to alleviating the charge state dependence of ETD efficiency is 
to produce precursor ions in higher charge states either through super-charging or 
derivatization techniques. The addition of m-nitrobenzyl alcohol to the ESI solutions 
promotes super-charging of ions and subsequent ETD analysis of these highly charged 
precursor ions was enhanced through higher sequence coverage.P27P Another method was 
recently described for the analysis of peptides by derivatization of cysteine residues in 
peptides using N,N-dimethyl-2-chloro-ethylamine, which converts cysteines to highly 
basic dimethyl lysine (DML) moieties leading to a higher net charge states upon ESI and 
greater peptide sequence coverage upon ETD.P28P Alternatively, the analyte molecules of 
interest can be derivatized by attachment of fixed charge sites to shift them to higher 
charge states prior to electron-based activation.P16-19P McLuckey et al. incorporated fixed 
charges via attachment of trimethylammonium moieties to primary amine groups in 
disulfide-linked peptides and demonstrated that the relative preference for backbone 
cleavage or disulfide bond cleavage upon ETD was influenced by the number of mobile 





charge derivatization of peptides in conjunction with ECD. For example, Chamot-Rooke 
at al. showed that the addition of trimethyl-phenyl phosphonium cations to the N-termini 
of O-glycosylated and O-phosphorylated peptides increased the sequence coverage upon 
ECD.P16, 17P O’Connor et al. reported the derivatization of lysine side-chains and/or N-
termini via attachment of trimethylpyridinium and noted an increase in side-chain 
cleavages with a corresponding decrease in backbone cleavages upon ECD.P19P      
In this study we explore an alternative derivatization strategy based on the use 
of an S-alkylation reagent, (3-acrylamidopropyl)-trimethyl ammonium chloride (APTA), 
which introduces fixed charges to all free cysteine side-chains of peptides through a 
quaternary ammonium moiety, in conjunction with ETD analysis. The APTA reaction 
has been shown previously to improve the ionization efficiencies of peptides, as well as 
their water solubility, while also allowing the use of strong cation exchange 
chromatography for the separation of the derivatized peptides.P29, 30P Our primary interest 
was exploiting the addition of fixed charge sites to enhance the use of electron transfer 
dissociation for the characterization of cysteine-containing peptides. In this study, APTA 
is used to derivatize cysteine-containing peptides, including those from a tryptic digest of 
bovine serum albumin (BSA), prior to characterization by ETD-MS. 
 
6.3 EXPERIMENTAL 
6.3.1 Materials and Reagents 
All reagents were purchased from Sigma Aldrich (St. Louis, MO, USA), and all 





FQVVCG, HCKFWW, CDPGYIGSR, NRCSQGSCWN, somatostatin 
(AGCKNFFWKTFTSC), TGF-alpha (CHSGYVGVRC), and bactenecin 
(RLCRIVVIRVCR). Immobilized TPCK trypsin beads were purchased from Pierce 
Biotechnology (Rockford, IL, USA). Acetonitrile and methanol (HPLC grade) were 
purchased from Fisher Scientific (Fair Lawn, NJ, USA).   
 
6.3.2 Derivatization and Sample Preparation 
All disulfide bonds in the peptides or proteins were first reduced by adding a 5-
fold molar excess of dithiothreitol (DTT) to the peptide or protein (10 μL, 1 mM) in 
aqueous solution and incubating at 40 °C for 1 hr in the dark (per manufacturer’s 
recommended protocol for optimal efficiency). Immediately following reduction, the 
reduced peptide samples were split into three aliquots; one for iodoacetamide (IAM) 
alkylation, one for APTA derivatization, and one for DML modification. IAM-alkylation 
was performed by adding iodoacetamide (4 μL, 1 M) in ammonium bicarbonate buffer 
(pH ~8.0, 100 mM). This reaction was allowed to proceed at room temperature for 1 hr in 
the dark, followed by the addition of excess DTT to quench the alkylation reaction. The 
resulting products are ones in which the reduced thiols are converted to S-
carboxamidomethyl groups. APTA derivatization was achieved by reacting the reduced 
peptide solution with APTA (16 μL, 1 mg/mL in 50:50 ACN/ 100 mM ammonium 
bicarbonate buffer, pH 8.0) overnight at room temperature in the dark followed by 
freezing to terminate the reaction. The resulting products are fixed-charge 
trimethylammonium S-alkyl cysteine derivatives. DML modifications were initiated by 





for three hours at room temperature, producing carboxyamidomethyl cysteines. After 
incubation all peptides were desalted using Thermo Fisher PepClean CR18R spin columns 
and diluted for MS analysis as described above.   
For the BSA protein sample, 100 μL of immobilized TPCK-treated trypsin beads 
in 100 mM ammonium bicarbonate (pH ~8.0) were used to digest 10 μmol of protein. 
The protein was enzymatically digested overnight at 37 °C after which the beads were 
removed and the resulting tryptic digest was subjected to IAM-alkylation or APTA-
derivatization using the procedures outlined above.   
 
6.3.3 Mass Spectrometry 
Samples were diluted to 10 μM in 49.5/49.5/1 water/methanol/acetic acid solution 
(v/v/v) and were directly infused at 3 μL/min into a Thermo Fisher LTQ XL (San Jose, 
CA, USA) with ETD capabilities. All ETD experiments were conducted with 
fluoranthene as the radical anion electron-transfer reagent with a 100 ms reaction time. A 
Dionex UltiMate 3000 capillary high performance liquid chromatography (Sunnyvale, 
CA, USA) was used for all separations. Samples with a final concentration of either 10 
μM enzymatically digested protein or APTA-derivatized protein (1 μL injections) were 
introduced to a reversed-phase CR18R column. Eluents consisted of 0.1% formic acid in 
water (A) and 0.1% formic in acetonitrile (B) and were used to generate a gradient of 5% 
B for 5 min followed by a linear gradient to 90% B over 45 min at a flow rate of 4 
μL/min. Data dependent analysis was conducted for all LC-MS/MS analyses by first 





undertaken on the two most abundant peaks. A normalized collision energy of 35% was 
used for all LC-CID-MS analyses. 
 
6.3.4 Protein Identification 
Protein samples were identified using Sequest search software using the following 
parameters: 2 maximum miscleavages,  ± 0.5 Da fragment mass tolerance, ± 1.0 Da 
precursor mass tolerance and the appropriate fixed modification of Cys (either the 
iodoacetamide alkylation or the APTA alkylation). 
 
6.4 RESULTS AND DISCUSSION 
6.4.1 ETD of Model Peptides 
 It has been previously shown that the addition of a fixed charge to a peptide can 
lead to a significantly different fragmentation pattern from its native form.P17, 31-33P For 
example, fixed-charge derivatization schemes have been utilized extensively to simplify 
tandem mass spectra through the elimination of one series of fragment ions using a 
variety of different activation methods including PSDP32P, CIDP33P, IRMPDP34P, ECDP17P, and 
recently in our group with electron transfer with gentle collision activation (ETcaD).P35P  In 
the present study, we aim to improve the sequence coverage of peptides upon ETD 
analysis by increasing the charge states of peptides via attachment of quaternary amines 
to reduced cysteine residues. Cysteine residues are a logical choice for implementation of 
selective derivatization strategies owing to their high reactivity and low abundance in 
proteins which allows streamlined subsets of peptides to be targeted. As demonstrated in 





reduced cysteine residues and leads to higher charge states that result in greater sequence 
coverage, including production of key diagnostic ions that allow characterization of both 
the C- and N-termini. We also compare the ETD results obtained for APTA-derivatized 
peptides having fixed charge sites to peptides in which the cysteines are reduced and 
IAM-alkylated and to the same peptides for which the reduced cysteine residues are 
converted to dimethyl lysine analogs, which are more basic moieties that also afford 
higher charge states (but not fixed charge sites). IAM is commonly used to prevent the 
recombination of disulfide bonds in reduced peptides by formation of S-
carboxamidomethyl derivatives which are easily ionized by ESI and MALDI-MS.  The 
DML derivatization procedure was shown previously to substantially increase both ETD 
efficiencies and sequence coverage obtained for cysteine-rich peptides.P22P  
 
 
Figure 6.1 DTT reduction and alkylation of cysteines, dotted lines represent cleavage 




























































A series of cysteine-containing model peptides were derivatized using the three 
alkylating reagents, IAM, DML, and APTA (Figure 6.1), and subsequently characterized 
by CID and ETD mass spectrometry. The APTA alkylation reaction is extremely 
selective for available cysteines through the alkylation of their thiol groups following the 
reduction of the disulfide bonds.P33,40P The reaction, as shown in Figure 6.1, results in the 
addition of 170 Da and a permanent positive charge at each thiol. It is well known that 
molecules with fixed charges often have higher ionization efficiencies and thus yield 
more intense ions, enhancing the detection of low abundance cysteine-containing 
peptides in complex mixtures.P29, 30, 36P The APTA derivatization efficiencies are estimated 
to be approximately 70% based on the ratio of the summed areas of all APTA-derivatized 
products relative to the summed areas of all APTA-derivatized products and unmodified 







Figure 6.2 ETD product ion mass spectra of NRCSQGSCWN (A) doubly charged 
IAM-alkylated, (B) triply charged DML analog, and (C) triply charged 
APTA-derivatized.  IAM-alkylation is denoted by ∆, DML-modification 
by P■P, APTA-derivatization by ᴏ, APTA-peptide reporter ions by φ, 
multiply charged fragment ions by * and neutral HR2RO/NHR3R losses by #.  
The unmodified peptide is represented by M while the selected precursor 
ion by .    
 
Representative examples of the ETD mass spectra obtained for a cysteine-
containing peptide, NRCSQGSCWN, after each of the three derivatization procedures 
(IAM, DML, and APTA) are shown in Figure 6.2. The highest charge state of the 
modified peptides were selected for ETD, corresponding to 2+ for the IAM-derivatized 
peptide, which has neither a fixed charge site nor an additional highly basic site; 3+ for 
the DML-derivatized peptide, which has an additional basic site; and 3+ for the APTA-






















































































derivatized peptide, which has a fixed charge site. As shown for the IAM-derivatized 
peptide, very few sequence ions (cR6R, cR7R, and cR8R) are observed upon ETD, providing 
incomplete sequence coverage. In addition, these three c-ions allow the position of only 
one cysteine residue to be pinpointed. For the DML-modified peptide (Figure 6.2B), the 
ETD mass spectrum displays far more complementary c and z sequence ions, and the 
resulting sequence coverage (see inset of Figure 6.2A) is greatly improved although 
there are still gaps near the termini as the cR2R, cR9R, zR1R, and zR8R ions were not observed. The 
ETD mass spectrum for the APTA-derivatized peptide reveals the entire c series as well 
as nearly the entire z series of product ions (Figure 6.2C). The latter mass spectrum 
provides the most extensive sequence coverage and thus affords confident assignment of 
the peptide sequence, along with identification of the positions of both cysteine residues. 
Moreover, upon ETD the formation of fragment ions in multiple charge states is 
minimized for the APTA-modified peptides as illustrated in Figure 6.2C. Upon DML 
derivatization, a significant number of multiply charged product ions crowd the 500-700 
m/z range which is consistent with previous results for ETD of DML analogs of other 
cysteine-containing peptides.P28P 
A comparison of the ETD and CID results for a series of model peptides 
derivatized by the three methods is summarized in Figure 6.3. The number of sequence 
ions (c-, z-, and y-type ions for ETD and a-, b-, and y-type ions for CID) are displayed in 
bar graph form for the highest charge states of each modified peptide. The ETD 
efficiencies and sequence coverages were significantly diminished for the lower charged 
peptide cations as the dominant reaction pathway was charge reduction without 





typically yielded the greatest number of c, z, and y ions. The sequence coverage of the 
APTA-modified peptides was consistently greater than that of the IAM-alkylated 
peptides and usually better than that obtained from the DML-modified peptides. For 
example, for bactenecin (RLCRIVVIRVCR), ETD of the triply charged IAM-alkylated 
peptide produced one y ion, eight c ions, and six z ions, ETD of the DML-derivatized 
peptide (5+) yielded one y ion, nine c ions, and nine z ions, and ETD of the APTA-
modified peptide (5+) produced seven y ions, eleven c ions, and eleven z ions. Among the 
three types of derivatized peptides evaluated in the present study, the overall sequence 
coverage obtained upon ETD of the IAM-alkylated peptides was the least comprehensive 
as these derivatized peptides were predominantly observed in lower charge states due to 
the lack of additional highly basic or fixed charge sites. As previously noted, precursor 
cations in lower charge states tend to favor non-dissociative processes upon electron 







Figure 6.3 Number of diagnostic ions produced by ETD and CID for model peptides 
upon modification; IAM=IAM-alkylated, DML=dimethyl Lys analog, 
APTA=APTA-derivatized. 
  
Two contributing factors led to the observed enhancement in sequence coverage 
for the APTA-peptides relative to the DML-peptides. First, the APTA-modified peptides 
frequently undergo backbone cleavages close to the peptide termini upon ETD that were 
not routinely observed for the DML-peptides. These include cleavages between the 
terminal and penultimate residues leading to the formation of the single C-/N-terminal 
residue ion (e.g., cR1R, zR1 Rand yR1R) and their complementary fragment ions (e.g., zRn-1R, cRn-1R). 




































































































































































































for the APTA-peptides. The y fragment ions are commonly produced by CID, not ETD, 
but they are in fact reasonably abundant product ions observed upon ETD of the APTA-
peptides. The increase in abundance of y ions for the APTA-peptides may be related to 
the presence of fixed charge sites at all cysteine residues. It has been proposed that the 
formation of y-type ions upon ECD is enhanced for peptides that can adopt zwitterionic 
structures as well as those peptides that have basic residues at the C-terminus or those 
with proline residues (i.e. peptides in which protons can migrate to proline amide or other 
backbone amide positions).P37P Peptides that can adopt zwitterionic structures promote 
greater proton mobility, thus allowing proton localization at the backbone amide 
nitrogen.P36P The highly basic sites introduced at cysteine residues encourage the formation 
of  zwitterions, presumably increasing the production of the y-type ions. Moreover, as 
ETD does not frequently yield products from the N-terminal side of proline residues,P7P 
there are often gaps in the sequence coverage. This shortcoming can be compensated 
(albeit at the expense of more elaborate data collection) by undertaking complementary 
CID analysis of the peptides because CID often causes enhanced cleavages N-terminal to 
proline residues.P38-40P However, the production of y ions stemming from cleavages N-
terminal to proline residues was common upon ETD of the APTA-peptides in the present 
study, thus providing another set of N-terminal ions to improve the confidence in 
identifying the sequences. Both of these improvements can be visualized in Figure 2, in 
which the number of y ions produced is increased for the APTA-peptides in comparison 
to the DML-peptides and IAM-peptides.     
Another way of assessing the analytical value of the ETD results for the IAM-, 





values, defined by Coon et al. as the number of observed c- and z-type ions for a 
sequence divided by the total number of theoretically possible c- and z-type fragment 
ions.P41P Larger percent fragmentation values signify higher sequence coverage. The 
percent fragmentation is plotted as a function of the m/z values of the peptides in Figure 
6.4.  ETD of the APTA-peptides generally affords higher percent fragmentation values 
than that obtained for the IAM-peptides or DML-peptides. The decrease in percent 
fragmentation with increasing precursor m/z has been previously documented and leads 




Figure 6.4 Percent fragmentation obtained upon ETD of model peptides as a function 
of precursor m/z and derivatization method.  Percent fragmentation is 
defined as the number of observed fragment ions divided by the total 
number of possible fragment ions (all c- and z-type ions).   
 
The ETD dissociation efficiencies, defined as the sum of the abundances of the z, 





including any backbone fragments, product ions due to neutral losses, reporter ions, 
charge reduced species and any surviving precursor ion), were calculated and expressed 
as percentages for the highest charge state (as listed in Figure 6.3) for the APTA-, DML-, 
and IAM-derivatized peptides. The dissociation efficiencies for the APTA- and DML-
peptides were comparable, averaging 47% and 53% for the series of model peptides, 
respectively, and only 18% for the IAM-peptides.   
In addition to the benefits of the greater sequence coverage afforded upon ETD of 
the APTA-peptides, a group of characteristic reporter ions is also produced. Two reporter 
ions of m/z 117 and 205 offer a secondary means of readily pinpointing cysteine-
containing peptides. These two reporter ions are likely produced through cleavage of the 
APTA moiety (m/z 117 and 205), as illustrated in Figure 6.1 by the dashed cleavage 
lines. These ions are produced in reasonably high abundance for all charge states of the 
APTA-peptides, thus allowing consistent tracking of all of the APTA-peptides as seen in 
Figures 6.2 and 6.5.   
Based on the similar or better sequence coverage obtained for the peptides after 
APTA derivatization, the attachment of fixed charges (e.g., via APTA) rather than basic 
sites (e.g., via DML) was pursued for the remainder of the comparative study. 
 
 
6.4.2 ETD of BSA Tryptic Digest 
Following the assessment of the results obtained for the series of model peptides 
derivatized by the three reagents, tryptic peptides of bovine serum albumin were similarly 
analyzed. The BSA tryptic peptides were either alkylated with IAM or converted to 





alkylation procedure, although efficient, led to the production of derivatized peptides in 
lower charge states (predominantly 2+ or 3+ depending on the length of the peptide) 
upon ESI than did the APTA derivatization (charge states of 3+ to 7+ observed). 
Consequently, ETD of the IAM-alkylated peptides largely resulted in non-dissociative 
charge transfer yielding singly charged radical peptides and formation of few sequence 
ions. An example can be seen in Figure 6.5A for the tryptic peptide 
YNGVFQECCQAEDK, in which only seven c- and z-type ions and two y-type ions are 
observed, thus diminishing the identification of the peptide. In comparison, ETD of the 
analogous APTA-modified peptide led to the production of far more sequence ions, 
including complete series of c, z ions, and y ions and minor abundances of charge-
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Figure 6.5 ETD product ion mass spectra of the BSA tryptic peptide 
YNGVFQECCQAEDK for the (A) doubly charged IAM-alkylated, and 
the (B) quadruply charged APTA-derivatized.  IAM-alkylation is denoted 
by ∆, APTA-derivatization by ᴏ, APTA-peptide reporter ions by φ, and 
neutral HR2RO/NHR3R losses by #.  The unmodified peptide is represented by 
M, while the precursor ion by .  
 
The results for the entire tryptic digest of BSA are summarized in Figure 6.6 
which shows the number of diagnostic z, c, and all y and b ions upon ETD and y, b and a 
ions upon CID for twenty-five IAM- and APTA-derivatized tryptic peptides. In order to 
maximize the number of diagnostic ions formed, ETD and CID were undertaken on the 
highest charge states observed for each of the IAM- and APTA-peptides. The APTA 
derivatization allowed analysis of many peptides that were either below the mass range or 
too low in abundance to be isolated upon conventional alkylation. For example, the two 
smallest peptides, CASIQK and GACLLPLK, were solely identified following the APTA 
derivatization/ETD strategy because without the APTA addition the m/z values of the 
multiply charged states of these small peptides fell below the m/z range analyzed. 
Moreover, the singly charged analogs with correspondingly higher m/z values do not 
produce charged products upon ETD. In addition, three peptides SLHTLFGELCK, 
SQYLQQCPFDEHVK, and AFSLQYLQQCPFDEHVKLVNELTEFAK, were not 
detected after the IAM-alkylation procedure. In contrast, upon APTA derivatization these 
three peptides exhibited greater ionization efficiencies that allowed their detection and 







Figure 6.6 Number of diagnostic ions produced by ETD and CID for BSA tryptic 





























































































present, that derivatized peptide was not detected in any charge state and 
could not be analyzed.   
There were three cases where the APTA-derivatized tryptic peptides were not 
detected (QNCDQFEK, ECCDKPLLEK, and CCAADDKEACFAVEGPK). Upon 
derivatization of all available cysteines and a corresponding increase in the charge states 
of these peptides, the m/z values of the resulting derivatized peptides fall below m/z 400 
(the lowest mass scanned in the full mass spectra to eliminate LC solvent peak 
interferences) and thus these ions would not be detected. Despite this shortcoming, ~50% 
of BSA was characterized through the investigation of solely the APTA-derivatized 
cysteine-containing peptides. For all cases in which both IAM- and APTA-derivatized 
peptides were observed, ETD of the fixed charge APTA-peptides provided significantly 
greater sequence coverage than that obtained for the IAM-derivatized peptides. The same 
trend does not hold true for the analogous CID results. In some cases, the IAM-alkylated 
peptides yielded better sequence coverage, whereas in other cases the CID of the APTA-
peptides gave greater sequence coverage. These CID results were not unexpected 
considering that the APTA-derivatization procedure adds fixed charges, not mobile 
protons that facilitate many of the fragmentation pathways observed by CID.P42, 43P   
As described earlier, a second way of assessing the analytical value of the ETD 
results for the derivatized peptides involves comparing the percent fragmentation values. 
The percent fragmentation values are plotted as a function of the m/z values of the 
derivatized tryptic peptides in Figure 6.7. ETD of the APTA-peptides generally affords 
higher percent fragmentation values than that obtained for the IAM-peptides, again 
reflecting the merits of employing the fixed charge derivatization procedure for cysteine-







Figure 6.7 Percent fragmentation obtained upon ETD of tryptic peptides from BSA as 
a function of precursor m/z and derivatization method.  Percent 
fragmentation is defined as the number of observed fragment ions divided 
by the total number of possible fragment ions (all c- and z-type ions).  
 
The ETD dissociation efficiencies were also calculated for the series of 
derivatized tryptic peptides shown in Figures 6.6 and 6.7. The dissociation efficiencies 
for the APTA-peptides averaged 56%, whereas the dissociation efficiencies for the IAM-
peptides averaged only 17%.  As expected from the well-recognized charge state 
dependence of ETD, the more highly charged APTA-peptides yield greater relative 
abundances of informative sequence ions upon ETD. This consistent increase in sequence 
ions also improves the application of search algorithms used to identify peptide 
sequences, thus exploiting the advantage of fixed charge derivatization in conjunction 
with ETD. As proof of concept, the HPLC data obtained for the tryptic digests of both 




























database. In both cases BSA was identified using the search parameters described in the 
experimental section with the highest probability score. For the IAM alkylation method, a 
total of 21 peptides were correctly identified with high confidence leading to a 
SEQUEST score of 582 and sequence coverage of 55%.  For the APTA-modified BSA 
run, the search was limited to only APTA-modified cysteine peptides, yielding the correct 
identification of 15 peptides with a score of 3700 and 23% protein coverage. This 6-fold 
increase in score accompanied by a decrease in sequence coverage proves that the 
selective study of tagged Cys peptides from a complex mixture is a powerful 
identification database.     
 
6.5 CONCLUSIONS 
The cysteine-selective fixed charge reagent, APTA, offers advantages over other 
charge enhancement strategies and traditional alkylation procedures in conjunction with 
ETD mass spectrometric analysis of peptides. The APTA derivatization procedures yields 
peptides in higher charge states upon ESI, and ETD of the APTA-modified peptides 
results in the formation of nearly complete series of c, z, and y ions. The APTA 
modification increased the sequence coverage by enhancing fragmentation near the 
peptide termini as well as production of y ions not typically observed upon ETD. ETD of 
the APTA-peptides also resulted in higher fragmentation percentages (number of 
observed fragment ions/number of theoretically possible fragment ions) and greater 
dissociation efficiencies than obtained for conventional IAM-alkylated peptides. 
Generation of a pair of reporter ions upon ETD of the APTA-peptides offered a 
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Introduction of a Hydrazone Bond to Facilitate Mapping Novel Protein 
Surface Accessibility through Electron Transfer Dissocation 
 
7.1 OVERVIEW 
A protein’s surface is especially important for its role in protein-protein 
interactions and protein-ligand binding. Mass spectrometry can be used to give low 
resolution structural information when used in combination with derivatization methods 
that target surface accessible amino acid residues. However, pinpointing the resulting 
modified peptides upon enzymatic digestion of the surface-modified protein is 
challenging due to the complexity of the peptide mixture and low abundance of modified 
peptides. Here a novel reagent, NN, is presented that allows facile identification of all 
modified surface residues through a preferential cleavage upon activation by electron 
transfer dissociation coupled with a data-dependent MSP3P scan to pinpoint the modified 
residue in the peptide sequence. Using this approach, the standard protein, ubiquitin, is 
used to show the correlation between percent reactivity and solvent accessibility. In 
addition, the surface accessibilities of two other proteins, eIF4E and PARP-1 Domain C, 
were studied.   
 
7.2 INTRODUCTION 
In the past decade the number of protein sequences without solved structures in 
the Protein Data Bank library has increased dramatically.P1P  Determination of the 
correlation between protein structure and function remains a primary objective of 





unraveling the three dimensional structures of proteins.   The most common techniques 
used to determine higher order structure of a protein are nuclear magnetic resonance 
(NMR) and X-ray crystallography; however these techniques are not universal due to 
practical limitations related to protein size, the inability to crystallize certain proteins, or 
limited sample amounts.  Due to these restrictions, the development of mass 
spectrometry-based strategies has gained traction due to their speed and sensitivity and 
have shown great promise for low resolution protein structure analysis. 
 A number of protein labeling techniques have been used in combination with 
tandem MS analysis to provide low resolution structural information including hydrogen-
deuterium exchange (HDX), crosslinking, and covalent chemical modifications prior to 
proteolytic digestion.P2P  HDX provides the most detailed information about a structure as 
it probes the entire protein backbone; however, spatial resolution can be greatly limited 
due to back-exchange of the deuterium to hydrogen before analysisP3P or 
hydrogen/deuterium scrambling during tandem MS.P4P  Electron-based dissociation 
methods have been able to overcome much of the error due to scrambling, but the 
limitations due to back-exchange still remain great.P5, 6P Chemical modifications are used 
to covalently label specific or nonspecific amino acid side chains, thus eliminating the 
problem of back-exchange and scrambling.P2P The foundation of this method is based on 
the premise that amino acids that are exposed to solvent and are therefore accessible to a 
chemical labeling agent will be modified, whereas those that are buried will be modified 
slowly or not at all.  This type of labeling provides information about the identities of the 
amino acids accessible to the reagent in solution, resulting in a low resolution map of the 





chains reflects their potential participation in protein-protein or protein-ligand 
interactions. The chemical modification methods are frequently combined with a bottom-
up approach in which the modified proteins are subsequently enzymatically digested to 
facilitate MS/MS analysis.  Crosslinking, a specific form of chemical modification, 
provides information about structure by creating new intramolecular or intermolecular 
bonds between specific amino acids with distance constraints on the location of the two 
amino acids linked due to the size of the linker.P7P  Since new bonds are formed between 
contact areas of the protein, even if remote in terms of the primary sequence, sequencing 
these sites through tandem MS can prove challenging. Identification of the crosslinked 
peptides provides distance constraints that can be used to re-construct the contact points 
and conformation of the protein(s).  With single covalent modifications of amino acids 
(not formation of crosslinks), the analysis is often more straightforward as the 
modification can be treated as a post-translational modification, thus allowing most 
searching algorithms to be used for the identification of the digested modified peptides. 
In this case, the identification of the modified residues reveals the exposed regions of the 
protein relative to the inaccessible regions, therefore reflecting conformational 
information.    
Lysine is one of the most targeted amino acids for chemical labeling due to its 
intrinsically high reactivity, thus making it amenable to efficient modification.  
Moreover, the positively charged, polar side chain of lysine under physiological pH 
conditions means that lysines are more often located on the hydrophilic surface of 
proteins and consequently more often involved in protein-protein or protein-ligand 





covalent modification strategy based on monitoring the differential reactivity of selected 
residues in the presence/absence of the interacting protein or ligand, indicating their 
involvement in a binding interaction.  Several different Lys-specific chemical 
modification methods have been reported such as aminoacetylationP8-13P, amidination,P14, 15P 
and many biotin labeled reagents.P16-20P These modifications have been used to characterize 
the topology of multiple proteins, protein-ligand complexes and protein-protein 
interactions.    
 The development and application of new crosslinking and surface 
accessibility strategies has been impeded by the difficulty of detecting the low abundance 
crosslinked or modified peptides amidst a large array of more abundant unmodified 
peptides produced upon enzymatic digestion of the proteins or protein complexes.  This 
detection problem has been addressed by efforts to selectively enrich the modified 
peptides,P21-27P incorporation of isotopic labels in the reagents to give the modified peptides 
distinctive isotopic signatures,P28-32P and development of selectively cleavable reagents that 
yield a traceable neutral loss or reporter ions upon MS/MS analysis.P33-37P  In the context of 
surface accessibility studies, Reid et al. has done this using a ‘fixed charge’ sulfonium ion 
with specificity for methionineP38P, cysteineP39P and lysineP40P targets where upon collision 
induced dissociation (CID) the exclusive loss of a dialkylsulfide (e.g. a neutral loss of 62 
Da) is indicative of a modified species.  Our group has previously found that a N-N 
hydrazone bond was selectively cleaved upon electron transfer dissociation.P37P Bis-
arylhydrazone crosslinked peptides were created by reacting succinimidyl 4-
formylbenzoate modified peptides with succinimidyl 4-hydrazinonicotinate acetone 





through the production of two partially modified peptides, one even-electron product ion 
and one odd-electron product ion, following cleavage of the N-N hydrazone bond.   Here 
we describe a new reagent, NN (see Figure 7.1), that modified Lys and N-terminal 
residues by incorporation of a N-N hydrazone bond.  Upon electron transfer dissociation 
(ETD), the preferential cleavage of the N-N bond leads to a dominant loss of 93 Da from 
all charge-reduced species that can readily distinguish all modified peptides from 
unmodified ones.  The characteristic loss of 93 Da can be used to trigger a subsequent 
CID event (MSP3P) to sequence the modified peptides and identify their locations within 
the protein sequence.  Because all modified peptides are uniquely pinpointed based on the 
characteristic neutral loss from the charge reduced species and this product retains a 
unique mass tag too yet in a lower charge state, the resulting MS/MS/MS fragment ions 
are produced in lower charge states that increase the confidence of their identification. To 
initially test the method and reagent, a model protein (ubiquitin) was used to evaluate the 
feasibility of the surface interrogation.  Following the proof of concept, the surface 




7.3.1 Materials and Reagents 
Ubiquitin, proteomics grade trypsin, endoproteinase Arg C and Glu C were 
purchased from Sigma (St. Louis, MO). PARP 1 Domain C protein was provided by Dr. 
Hung-wen Liu (Department of Pharmacy, University of Texas at Austin) and eIF4E was 





University of Texas at Austin).  All other chemicals and solvents were purchased from 
Fisher scientific (Fairlawn, NJ).  
 
7.3.2 Synthesis of (E)-2,5-dioxo-1-((4-((2-(pyridine-2-
yl)hydrazono)methyl)benzoyl)oxypyrrolidine-3-sulfonic acid (NN) 
The surface accessibility reagent, NN, was synthesized in house as summarized in 
the Figure 7.1 below. NN was synthesized by refluxing 7.3 mmol of 2-hydrazinopyridine 
and 9.7 mmol of 4-formylbenzoic acid in 20 mL of toluene for four hours.  A yellow 
precipitate was isolate by vacuum filtration and washed with toluene and ethyl acetate 
(82.0%). One equivalent of the isolated hydrazonal intermediate was coupled with two 
equivalents of N-hydroxysulfosuccinimide using two equivalents of 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide and a catalytic amount of 4-dimethylaminopyridine 
in dimethylformamide for 24 hours. Upon completion, the reaction was rotovaped and 
washed with dichloromethane and water. The product was triturated in hexanes before 








Figure 7.1 Synthesis of NN; NN was synthesized by coupling 4-formylbenzoic acid 
(1) and 2-hydrazinopyridine (2) and via hydrazone bond formation. The 
hydrazone intermediate (3) was subsequently reacted with sulfo-N-
hydroxysuccinimide to install the amine-reactive NHS terminus producing 
NN (4); preferential ETD cleavage is marked indicating the loss of 93 Da 
from all charge reduced species.   
 
7.3.3 Derivatization and Sample Preparation 
Each protein (1 mM, 25µL) was mixed with NN at a variety of molar ratios relative to 
NN (20 mM) in PBS buffer at pH 7.2 - 7.4.  The protein:NN ratios were varied from 1:2 to 
1:10.   All reactions were carried out at room temperature overnight and cleaned up using 10 
kDa MWCO filters the following morning. Derivatized samples were then split into three 
aliquots for digestion. For tryptic digestion, the derivatized protein (8 nmol) was diluted with 







































protein to trypsin overnight at 37PoPC.  For GluC digestion, the derivatized protein (8 nmol) 
was diluted with the GluC Reaction Buffer from BioLabs, consisting of 50 mM Tris-HCl and 
0.5 mM Glu-Glu buffer at pH 8.0, and digested with 1 mM GluC in water in a 1:20 w/w ratio 
overnight at 37PoPC.  For ArgC digestion, the derivatized protein (8 nmol) was diluted in 50 
mM NHR4RHCOR3R at a pH of 8.0 with a small addition of 20 mM CaCHR3RCOOH to enhance 
digestion, and then digested using a 1:16 w/w molar ratio of protein to ArgC at 37PoPC 







7.3.4 Mass Spectrometry and Liquid Chromatography 
All experiments were undertaken on a ThermoFisher LTQ XL linear ion trap 
mass spectrometer (San Jose, CA) equipped with an ETD unit.  Direct infusion analysis 
on the LTQ XL was done using an online nanoESI setup as previously described using a 
flow rate of 3 μL/min at a concentration of 10 μM in 49.5:49.5:1 MeOH:H2O:Acetic 
acid.41  An ESI voltage of 2 kV and a heated capillary temperature of 180o C were used 
for experiments on the LTQ XL.   Liquid chromatography was performed using a RLSC 
Dionex UltiMate 3000 system (Sunnyvale, CA). An Agilent ZORBAX 300Extend-C18 
column (Santa Clara, CA) (150 × 0.3 mm, 3.5 µm particle size) was used for all 
separations. Eluent A consisted of 0.1% formic acid in water and eluent B 0.1% formic 
acid in acetonitrile. A linear gradient from 5% eluent B to 40% eluent B over 65 min at 
0.3 µL/min was used. Injections of approximately one picomole were used for each 
digested sample. For all LC-MS/MS runs, the first event was the full mass scan (m/z 
range of 400 – 2000) followed by five sets of consecutive MS/MS events on the five most 
abundant ions from the full mass scan. The first event in each set was acquisition of an 
ETD spectrum using an electron transfer reaction time of 100 ms.  Following ETD, the 
most abundant fragment ion was subsequently activated by CID using a q-value of 0.25, a 
normalized collisional energy of 35%, and a collision activation of 30 ms. The maximum 
injection time for all events was set to 100 ms, and each mass spectrum and tandem mass 






7.3.5 Determination of Surface Accessibility 
Upon identification as a modified peptide from the ETD spectrum based on the 
characteristic loss of 93 Da, peptides were sequenced manually using the subsequent CID 
fragmentation pattern of the charge-reduced species. The percent reactivity was calculated 
based on the sum of the peak areas of all peptides containing a modified residue based on the 
total ion chromatographic (TIC) profiles and integrated using QualBrowser, divided by the 
sum of the area of all peptides containing the unmodified and modified residue as shown in 
equation 7.1. 
 
𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 7.1 ∶ % 𝑅𝑒𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦
=  
∑𝐴𝑟𝑒𝑎 𝑜𝑓 𝑎𝑙𝑙 𝑝𝑒𝑝𝑡𝑖𝑑𝑒𝑠 𝑐𝑜𝑛𝑡𝑎𝑖𝑛𝑖𝑛𝑔 𝑚𝑜𝑑𝑖𝑓𝑖𝑒𝑑 𝑟𝑒𝑠𝑖𝑑𝑢𝑒 𝑛
∑𝐴𝑟𝑒𝑎 𝑜𝑓 𝑎𝑙𝑙 𝑝𝑒𝑝𝑡𝑖𝑑𝑒𝑠 𝑐𝑜𝑛𝑡𝑎𝑖𝑛𝑖𝑛𝑔 𝑟𝑒𝑠𝑖𝑑𝑢𝑒 𝑛
 
 
For proteins where a known structure was not available, ITASSER was used to predict a 
structure based on the primary sequence of the protein.P1P Theoretical surface accessibilities 
for all Lys side chains and the N-terminus were calculated using GetArea software onlineP42P 
with all parameters set as the default values based on known or ITASSER model structures 
as indicated.  
7.4 RESULTS AND DISCUSSION 
7.4.1 Design of NN Surface Accessibility Reagent 
NN was designed to selectively react with primary amines, such as the ε-amino 





(NHS) coupling.  Second, NN contains a N-N hydrazone bond that has previously been 
shown to preferentially cleave upon ETD, thus facilitating the identification of modified 
peptides based on an easily monitored MS/MS reaction. For NN, the characteristic 
fragmentation upon ETD results in the neutral loss of 93 Da from the charge-reduced 
precursor and the number of consecutive neutral losses is indicative of the number of 
modified residues.  This pathway is the dominant fragmentation pathway of NN-modified 
peptides upon ETD, and it allows the convenient implementation of a data dependent scan 
mode in which the acquisition of a CID spectrum can be triggered for the most abundant 
fragment ion produced upon ETD. The resulting CID (MSP3P) spectrum allows the peptide to 
be sequenced and the location of the modification to be pinpointed.   For the reactions of NN 
with each protein, the protein:NN ratios were varied over a range of values in order to 
optimize reaction efficiencies while maintaining tertiary protein structure. At lower molar 
ratios, only the most accessible sites are modified and the structural integrity is most readily 
maintained. With higher molar ratios, reaction efficiencies at less accessible modification 
sites increased, thus enhancing detection of those sites. 
 
7.4.2 Ubiquitin 
A model protein, ubiquitin, was utilized to test the efficiency of the NN reaction 
and its suitability for measurement of surface accessibility.  Ubiquitin contains eight 
primary amine sites including seven Lys and the N-terminus. The reaction of ubiquitin 
with the NN reagent is efficient, as evidenced by the ESI-mass spectrum of the protein 








Figure 7.2 ESI mass spectrum of ubiquitin after reation with NN at a 1:2 protein: NN  
molar ratio.  Triangles indicate NN modification.   
 
Subsequent tryptic digestion and LC-MS/MS analysis results in identification of 9 
unmodified peptides plus 14 modified peptides, the latter based on the characteristic N-N 
bond cleavage upon ETD followed by data-dependent CID.  The abundances of the 
unmodified peptides and NN modified counterparts are quantified through manual 
integration of peak areas in the TIC profile using QualBrowser software, and the results 
are summarized in Table 7.1 along with the solvent accessibilities estimated from the 



























GetArea SA % % Reactivity
UBI1 Trypsin GluC ArgC
Met 1 14 26±13 25±22 34±23
Lys 6 59 96±6 71±10 56±30
Lys 11 63 22±9 13±12 14±27
Lys 27 11 1±0.5 0 0
Lys 29 36 15±7 0 0
Lys 33 47 59±30 71±29 0
Lys 48 56 58±34 66±29 35±23





Table 7.1 Comparison of Surface Accessibility to Percent Reactivity for Ubiquitin at 
a 1:2 protein:reagent molar ratio.  Solvent Accessibility was calculated 
using GetArea for pdb UBI1.  % Reactivity was calculated using equation 
7.1. 
 
When the solvent accessibilities, according to GetArea based on the previously 
determined tertiary structure, of these sites are compared, they range from 11 to 77%. 
Ubiquitin was reacted with NN using four protein/NN molar ratios from 1:2 to 1:10, yielding 
up to three modifications for the low molar ratio of 1:2 and up to five modifications for the 
higher molar ratios of reagent to intact protein.  The higher protein/NN ratios were used to 
enhance the modification and subsequent detection of some of the less accessible sites that 
might otherwise be non-detectable under more limiting protein:NN reaction conditions.  
These results are in general agreement with the expected solvent accessibilities of the amine 
sites given that four Lys residues have solvent accessibilities greater than 50% and one Lys is 
slightly lower at 47% based on the GetArea predictions.  These five Lys residues are situated 
on the surface of the protein and therefore are more accessible to modification whereas the 
other three primary amines reside on the interior of the tertiary structure, making their side-
chains largely inaccessible and unreactive.  Three proteases, trypsin, GluC and ArgC, were 
used to digest the protein, thus facilitating identification of the modified peptides in a 
bottom-up approach.  Although trypsin is the most popular protease for conventional 
proteomics strategies, it proves to be problematic for proteins modified at lysine sites, such as 
the NN-modified proteins in the present study, in which the modification disrupts proteolytic 





coverage of all three digests and thus provided information about some of the more 
inaccessible residues.   
Upon covalent modification of any protein, slight changes in structure are 
possible following derivatization. Thus to preserve the structure of the protein as much as 
possible, lower protein/NN molar ratios are used to limit the number of modifications per 
protein.  For ubiquitin, a 1:2 protein/NN ratio produced predominantly singly modified 
proteins with minor contributions of doubly and triply modified proteins, as shown in 
Figure 7.2. The solvent accessibilities of each of the eight possible modification sites of 
ubiquitin are compared to the percent modifications obtained from the NN reactions in 
Table 7.1.  
Upon digestion, the modified peptides were easily distinguished from unmodified 
peptides using ETD through the preferential cleavage of the NN bond. This cleavage 
leads to a loss of 93 from all charge reduced species. In addition, sequential losses of 93 
Da can be used to identify the number of modifications.  For example, the N-terminal 
peptide for ubiquitin, MQIFVKTLTGK, has two possible modification sites, the N-
terminal MR1R and KR7R. Upon ETD of the singly modified peptide a single loss of 93 Da 
from both the singly and doubly charged reduced species reflects the incorporation of a 
single NN modification (Figure 7.3A), whereas the doubly modified peptide shows two 







Figure 7.3 Preferential ETD cleavage of NN-modified peptides.  ETD of triply 
charged MQIFVKTLTGK with a single NN modification (A) and double 
NN modification (B). The sites of modification are indicated by bold 
underlined font.  Preferential ETD cleavage is indicated by the arrows. Ф 
indicates the precursor ion in each spectrum. 
 
In this example, the sites of modification can be pinpointed directly from the ETD 
spectra. For the singly modified peptide, the unmodified cR2R, cR3R, zR3R, and zR4R ions and the 
modified zR8R and cR7R ions localize the first modification on KR7R; for the doubly modified the 
absence of the unmodified cR2R, cR3R, zR3R, zR4R, zR5R, singly modified zR8R, and the doubly modified 
cR7R ions indicates the second modification is located at MR1R.  However, in some cases the 
location of modification cannot be pinpointed from the ETD spectrum alone due to 
insufficient fragment ions.   Thus, a subsequent CID (MSP3P) step was included to target 
the peptide after loss of 93 Da from the charge reduced species in a data dependent 
manner (see Figure 7.4 for an example from ubiquitin). This additional step ensured the 
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Figure 7.4 Identification of NN-modified peptides from ubiquitin; A. ETD of triply-
charged, singly modified GIPPDQQRLIFAGIKQLE, B. CID of NN-
cleaved peptide following ETD (precursor m/z 1021). An ETD reaction 
time of 100 msec and a collision energy of 35% was used. The site of 
modification is indicated by bold underlined font. * indicates 
water/ammonia losses. Ф indicates the precursor ion. 
 
For ubiquitin the most accessible residues are KR6R, KR11R, KR48R and KR63R all with 
calculated solvent accessibilities over 50% as shown in Table 7.1.  For all three digests KR6R, 
KR48R, KR11 Rand KR63R are among the most accessible sites with the best agreement obtained for 
the GluC and ArgC digests. KR27R and KR29R were shown to be the least accessible sites as they 
displayed no reactivity based on the GluC and ArgC results and very little reactivity for the 
set of trypsin results. These sites are heavily involved in hydrogen bonding on the interior of 
the protein. Our NN-based accessibility results are in general agreement with other surface 
studies that have been conducted for ubiquitin.P43, 44P The ArgC results gave the best 
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KR48R were slightly less accessible but much more so than the other four possible modification 
sites which were unreactive. The data obtained for the ArgC digest did not indicate any 
modification of site KR33R which was surprising since the ESI-MS/MS results for the other two 
digests showed high reactivity for this residue.  This may be due to the large size of the 
peptide that is anticipated for incorporation of the modification at this residue, thus making it 
unlikely to being detected.  
Our results also agree well with previous surface accessibility experiments performed 
on ubiquitin.  Upon amidination of the intact protein, the Reilly group found that the only 
inaccessible Lys was KR27R while all other possible modification sites were fully amidinated.P43P 
This Lys residue resides in the bottom of a hydrophobic pocket of ubiquitin’s tertiary 
structure, thus leaving it completely shielded from the solvent. For all three digests, using our 
NN reagent, Lys27 was observed with the lowest reactivity having only 1% reactivity based 
on results for the tryptic digest and 0% reactivity based on the analysis of both the GluC and 
ArgC digests. A top-down approach that utilized N-hydroxysuccinimidyl acetate to acetylate 
primary amines in ubiquitin found the reactivity trend to be Met1 ≈ Lys6 ≈ Lys48 ≈ Lys 63 > 
Lys 33 > Lys 11> Lys 27, Lys 29.P44P The Met1, Lys6, Lys48 and Lys63 sites were found to 
be the most reactive as they were involved in only weak hydrogen bonds involving other 
backbone carbonyl groups, while Lys 11, Lys 27, and Lys 29 were the least accessible due to 
their involvement in strong hydrogen bonds to carboxylic acids on other amino acid side 
chains. Our general reactivity trend was Lys6 ≈ Lys63 ≈ Lys 48 > Met 1 > Lys 33 > Lys 11 > 





found to be slightly less reactive than Lys 6, Lys 63, and Lys 48. This trend agrees well with 
the solvent accessibility predictions for the tertiary structure of ubiquitin from GetArea as the 
N-terminus had only a 14% surface accessibility while Lys 6, Lys 63 and Lys 48 all averaged 
about 60% reactivities. 
 
7.4.3 WHEAT EIF4E 
Upon successful demonstration of ETD-selective cleavage of the NN-modified 
peptides, the surface maps of two other proteins were evaluated using a similar strategy.  
The first, eukaryotic translation initiation factor-4E (eIF4E), is a crucial protein for the 
initiation of protein synthesis.P45P The structure has been extensively studied in mammalian 
and yeast cells but only recently in wheat.  Upon crystallization, a dimeric structure has 
been observed due to the artifactual formation of a disulfide bond. The only known 
monomeric structure was determined for a mutant bound to 7-methyl-GDP that cannot 
form the disulfide bond.P45P Wheat eIF4E has 15 Lys and the N-terminus as possible 
modification sites.  At the low molar ratios utilized for ubiquitin, minimal modifications 
were observed; however, at higher protein/NN molar ratios of 1:15 to 1:20, the dominant 








Figure 7.5 ESI-mass spectra of the NN-modified proteins.  A.  eIF4E at a 1:15 
protein:NN molar ratio, B. PARP at a 1:5 protein:NN molar ratio;  ∆= NN 
adduct 
 
The relatively high protein/NN ratio required for this protein, as well as the rather low 
modification rate, suggests that there are fewer highly accessible Lys residues and the native 
structure is only minimally disrupted after the first modification. The NN-modified protein 
was then subjected to enzymatic digestion using three proteases (trypsin, GluC, ArgC), 
followed by LCMS analysis.  In each case, spectral acquisition involved collection of full 
ESI mass spectra, followed by ETD spectra of the five most abundant ions and CID spectra 
of the most abundant fragment ion in each ETD spectrum.  All peptides were manually 
identified. The characteristic loss of 93 Da in the ETD spectrum was used to pinpoint the 
NN-modified peptides, and the subsequent CID spectrum was used to identify the sequence 
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Figure 7.6 Identification of NN-modified peptides from wheat eIF4E; A. ETD of 
triply-charged, singly modified AHPLENAWTFWFDNPQGK, B. CID of 
NN-cleaved peptide following ETD (precursor m/z 1145). ETD reaction 
time of 100 msec and collision energy of 35% was used. The site of 
modification is indicated by bold underlined font. * indicates 
water/ammonia losses. Ф indicates precursor ion. 
Unmodified peptides were identified using the initial ETD spectrum. The peak area for each 
modified residue was integrated and compared to all peptides containing the unmodified 
residue using QualBrowser software. 
 The artifactual dimeric structure of wheat eIF4E determined previously by X-ray 
and NMR measurements that arises from disulfide bond formation does not give a good 
representation of the monomer due to the extensive protein-protein interface.  A structure 
for a known mutant of wheat eIF4E has also been characterized previously as well, but 
this mutant is formed upon binding to 7-methyl-GDP which may cause considerable 
changes in tertiary structure, especially near the binding pocket. Therefore the tertiary 
structure of monomeric eIF4E was also predicted using the ITASSER program prior to 
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program and compared to the known mutant monomer and dimeric forms (Table 7.2). 
The known structure for the dimer, the 7-methyl-GDP mutant, and the monomer structure 




Figure 7.7 Structures for wheat eIF4E; dimer = PDB 2IDR, 7-Me-GDP mutant = 
PDB 2IDV.  The monomer is a predicted model from ITASSER, and key 
Lys residues (blue) are labeled. 
 
The solvent accessibility values calculated by GetArea for each structure were compared 
to the experimental percent reactivities determined for each enzymatic digest in Table 




























Table 7.2 Comparison of Solvent Accessibility to Percent Reactivity for wheat 
eIF4E reacted with NN at a 1:15 protein:NN molar ratio. Solvent 
accessibility was calculated using GetArea. Percent Reactivity was 
calculated using equation 7.1. “NA” indicates a peptide that was not found 
in neither its modified or unmodified form. Standard deviation ranged 
from 10-20% for all reacted sites. 
Based on the solvent accessibilities calculated for the monomer-predicted structure, three 
to four Lys residues are expected to exhibit much higher accessibility (above 90%) than 
Residue
Solvent Accessibility % % Reactivity
Dimer Mutant Monomer Tryptic GluC ArgC
Ala 1 46 65 41 2 11 5
Lys 18 43 34 96 6 5 47
Lys 52 76 74 50 0 0 0
Lys 63 5 9 20 0 NA 0
Lys 65 70 100 94 22 NA 11
Lys 69 100 20 48 0 0 0
Lys 80 27 20 20 0 NA 0
Lys 89 77 80 67 NA NA NA
Lys 122 40 38 92 61 5 70
Lys 131 31 26 31 0 0 0
Lys 144 68 73 66 0 2 0
Lys 147 22 15 13 0 0 0
Lys 153 42 42 84 0 0 0
Lys 165 80 43 50 0 0 0
Lys 169 40 81 91 45 9 34





all other possible modification sites; KR18R, KR65R, KR122R, and KR169R.   For the ESI-MS/MS 
results of the tryptic digest of the NN-modified protein, all four of these sites were 
identified as the primary sites of modification, thus indicating substantial NN reactivities.  
The N-terminus (AR1R) exhibited low accessibility (2%).  Upon increasing the molar ratio 
of protein:NN from 1:15 to 1:20, the reactivity for KR65R, KR122R, and KR169R all increased to 
100% whereas the reactivity of  KR18R showed little change and that of the N-terminus 
increased to 26%.  The latter change may signal a structural change for this part of the 
protein upon binding of NN to KR18R, thus opening up the structure so that the N-terminus 
is more readily accessible.  For the GluC digest, significant reactivity was observed for 
AR1R, KR18R, KR122R, and KR169R as seen in the tryptic digest.  However, based on the GluC digest, 
no reactivity values could be determined for KR63R, KR65R, KR80R or KR89R as no peptides were 
identified that contained these residues. We believe the absence of these peptides arises 
from the size of the digested peptide produced and possible spontaneous disulfide bonds 
forming following digestion. For the ArgC digest, again KR18R, KR65R, KR122R and KR169R proved 
to be the most reactive residues with AR1R showing a small amount of reactivity at a 1:15 
molar ratio.  The lack of reactivity of other Lys sites indicates these Lys residues reside 
on the interior of the protein leaving them unable to react with the NN reagent. 
 Based on the solvent accessibilities calculated for the ITASSER-predicted monomer, 
three to four Lys residues are expected to exhibit much higher accessibility (above 90%) than 
all other possible modification sites; KR18R, KR65R, KR122R, and KR169R.   For the ESI-MS/MS results 
of the tryptic digest of the NN-modified protein, all four of these sites were identified as the 
primary sites of modification, thus indicating substantial NN reactivities.  The N-terminus 





1:15 to 1:20, the reactivity for KR65R, KR122R, and KR169R all increased to 100% whereas the 
reactivity of  KR18R showed little change and that of the N-terminus increased to 26%.  The 
latter change may signal a structural change for this part of the protein upon binding of NN to 
KR18R, thus opening up the structure so that the N-terminus is more readily accessible.  For the 
GluC digest, significant reactivity was observed for AR1R, KR18R, KR122R, and KR169R as seen in the 
tryptic digest.  However, based on the GluC digest, no reactivity values could be determined 
for KR63R, KR65R, KR80R or KR89R as no peptides were identified that contained these residues. We 
believe the absence of these peptides arises from the size of the digested peptide produced 
and possible spontaneous disulfide bonds forming following digestion. For the ArgC digest, 
again KR18R, KR65R, KR122R and KR169R proved to be the most reactive residues with AR1R showing a 
small amount of reactivity at a 1:15 molar ratio.  The lack of reactivity of other Lys sites 
indicates these Lys residues reside on the interior of the protein leaving them unable to react 
with the NN reagent.  
 In comparing the experimental percent reactivities to the solvent accessibilities of the 
dimer, mutant, and TASSER-predicted monomer (Table 7.2), a few key variations are noted. 
In both the dimer and mutant forms, KR18R and KR122R are much less accessible whereas in the 
predicted monomer form, these residues have solvent accessibilities of 96% and 92% 
respectively, making them two of the most accessible sites. This notable difference mirrors 
the percent reactivities obtained from the NN protein modification results, confirming that 
both of these sites are two of the most reactive in wheat eIF4E. KR69R is 100% accessible in the 
dimer but is completely unreactive with NN based on analysis of the various protein digests, 
indicating it resides in the interior of the monomer.  KR172R for the 7-Me-GDP mutant is 





experimental percent reactivity value is zero. The site of this amino acid coincides with the 
binding location of the ligand 7-methyl-GDP in the mutant, thus suggesting that the bound 
ligand induces a significant structural change that does not occur in the native monomer. In 
light of these differences in predicted accessibilities and experimentally-determined 
reactivities, the NN reactivity results support the ITASSER predicted structure for the native 
monomer.    
 
7.4.4 PARP-1 DOMAIN C 
Poly(ADP-ribose) polymerase-1 (PARP-1) is a multimodular protein consisting of 
six domains (domains A-F) that is involved in several key biological processes including 
DNA repair and cell death.P46, 47P  Domain C has been shown to be vital to these functions 
and without it, PARP-1 ABDEF exhibits no activity. Domain C, by itself, also does not 
bind to DNA, confirming that it is the interactions of the entire multi-domain protein that 
stimulates biological activity.  Domain C has recently been isolated and studied by NMR 
to determine its solution structure. However, upon expression, only a shortened version 
with three fewer amino acids at its N-terminus and 15 fewer amino acids on its C-
terminus was identified by NMR spectroscopy, and no solution structural data exists for 
the true full form of the protein in its monomer form. In its full form, domain C contains 
18 Lys and the N-terminus as possible modification sites whereas the truncated version 
maintains all 18 Lys residues but with KR4R is also the N-terminus. Upon reaction of PARP 
with NN, several residues are modified even at low molar ratios (Figure 7.5B).  The NN-
modified protein was enzymatically digested using trypsin, GluC, or ArgC, and the 





demonstrated in Figure 7.8 (data dependent analysis entailing ETD followed by CID of 
the most abundant products).  
 
 
Figure 7.8 Identification of NN-modified peptides from PARP-1 Domain C. A. ETD 
of triply-charged, singly modified LLIFNKQQVPSGESAILDR, B. CID 
of NN-cleaved peptide following ETD (precursor m/z 1130). An ETD 
reaction time of 100 msec and a collision energy of 35% was used. The 
site of modification is indicated by bold underlined font. Ф indicates the 
precursor ion in each spectrum. 
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Table 7.3 Comparison of Surface Accessibility to Percent Reactivity for PARP-1 
Domain C reacted with NN in a 1:5 molar ratio protein:NN. Solvent 
accessibility for shortened structure was calculated using GetArea for pdb 
2JVN and for the full native structure based on the top five structures 
predicted by ITASSER (IT1-IT5). Percent reactivity was calculated using 
equation 7.1.  The bold box highlights the best model structure correlating 




Surface Accessibility % % Reactivity
Shortened IT1 IT2 IT3 IT4 IT5 Tryptic GluC ArgC
GLY 1 -- 76 90 100 72 79 98 100 100
LYS 4 100 87 78 91 76 88 98 85 95
LYS 7 81.6 70 79 71 75 91 41 38 5
LYS 10 85.9 76 63 64 71 77 25 0 10
LYS 20 20.6 16 20 29 30 10 14 0 9
LYS 24 65.2 56 48 37 70 40 7 0 0
LYS 25 65.4 55 62 57 58 56 0 0 0
LYS 33 49.6 35 33 34 34 56 0 0 0
LYS 40 93.1 76 87 85 77 82 4 1 8
LYS 76 94.9 62 45 45 48 62 0 0 7
LYS 91 54 67 55 63 67 45 0 0 0
LYS 95 73.7 50 36 42 41 44 0 0 0
LYS 102 64.8 69 66 63 52 37 52 0 0
LYS 108 70.3 67 92 84 74 71 23 65 35
LYS 117 25.3 37 42 42 37 13 16 0 0
LYS 118 88.3 46 50 46 55 62 0 100 98
LYS 120 24.6 41 53 50 52 26 37 0 0
LYS 122 43.4 84 83 74 76 53 0 0 0





 Since the tertiary structure of the full sequence version of domain C was 
unknown, its conformation was predicted by ITASSER,P1P resulting in five structures  
whose surface accessibilities were predicted by the GetArea program.  The surface 
accessibilities for the shortened domain C structures are shown in Table 7.3.  The percent 
reactivities obtained for the NN-modified peptides do not parallel the surface 
accessibilities predicted from the NMR structure,  as reflected by the differences in 
reactivities of a few key residues, including the highly reactive N-terminal GR1R and the 
non-reactive KR123 Rwhich was predicted to be 100% accessible based on the NMR 
structure.  Of the structures predicted by ITASSER, the fifth model (IT5) showed the best 
correlation with the experimental surface accessibility results.  This structure showed a 
highly reactive N-terminal portion of the protein with GR1R, KR4R, KR7R, and KR10R all having 
solvent accessibility values above 75% while the KR123R showed somewhat lower 
accessibility at 54%.  Upon examination of the structure of IT5, the low reactivity of KR123 
Rmay be rationalized by steric blocking by the chain of amino acids on the adjacent C-








Figure 7.9 Structures for PARP-1 Domain C, including shortened PARP = PDB 
2JVN and the full native PARP is predicted model 5 from ITASSER.  Lys 
residues (blue) with high accessibility are labeled. Boxed sections show 
key changes in structure recognized based on NN reactivity. 
 
The percent reactivities and predicted surface accessibilities of the other regions of the 
protein show good agreement with KR40R, KR76R, KR108R, and KR118R all predicted to be more than 
60% accessible, in line with the values from the NN modification reactions.  The only 
residue that does not correlate between the percent reactivity and solvent accessibility is KR7R.  
It was predicted as one of the more accessible residues but in all cases was shown to have 
poor reactivity in comparison to GR1R and KR4R.  We hypothesize that this deviation is due to 
























suspect that upon their modification by NN, the KR7R site is blocked, therefore hindering its 
reaction with the NN reagent. 
 
7.5 CONCLUSIONS 
A lysine-reactive surface accessibility reagent that incorporates an ETD-
selectively cleavable N-N hydrazone bond is reported. Enzymatic digestion of the surface 
modified proteins results in an array of peptides, some of which contain the hydrazone 
moiety. Upon ETD, the hydrazone bond cleaves selectively and with high efficiency to 
yield a loss of 93 Da from the charge-reduced peptide.  CID of the resulting neutral loss 
products via a data dependent MS3 strategy allows sequencing of the peptides and the 
modification sites to be pinpointed. This selective ETD/CID method is demonstrated for 
several proteins and provides maps of surface accessibility that are consistent with the 
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Mass spectrometry has proven extremely fruitful in the characterization and 
identification of biomolecules due to its sensitivity, speed, and ability to delve into their 
structure through fragmentation. As the field continues to progress and samples become 
more complex, the ability to distinguish between analytes and examine constituents of 
both high and low abundances becomes increasingly important. Selective derivatization 
can provide constraints on which analytes are targeted and identify specific structural 
details of interest. Tandem mass spectrometry remains an essential tool for creating 
diagnostic fingerprints of biological molecules and is the most common methodology for 
protein identification. However, most MS/MS methods yield partial sequence coverage, 
averaging around 75%, which is not always sufficient to assemble the complete primary 
sequence of a newly discovered protein or map its modifications. When tandem mass 
spectrometry is coupled with selective derivatization methods, advantageous chemistry 
can be used to enhance the mass spectrometric analysis. Several methods of incorporating 
a selective tag into proteins to enhance tandem mass spectrometry were discussed in this 
dissertation. 
In Chapter 3, a phosphate chromophore was added to the N-terminus of digested 
peptides to promote dissociation following IR irradiation. The efficiency of this 
derivatization method coupled to IRMPD was compared to traditional CID for 
sequencing of peptides to highlight the benefits of IRMPD, including the elimination of 





uninformative neutral losses from the precursor ion. The negative group of the phosphate 
also served to limit the fragmentation so that a sole series of ions was detected in the 
mass spectrometry, the y-series. The greater sequence coverage combined with simplified 
fragmentation spectra provided by IRMPD promoted greater confidence in the 
sequencing and identification of peptides and proteins. A novel phosphate isothiocyanate 
reagent was successfully synthesized and used to demonstrate enhanced 
photodissociation efficiency for a tryptic digest. 
High resolution is a key component to the analysis of large intact biomolecules. 
Chapter 4 discussed the integration of an IR laser with an orbitrap mass spectrometer to 
extend the use of IRMPD analysis to large intact biological molecules with high 
resolution/high mass accuracy detection. With the growing popularity of orbitrap mass 
analyzers, the introduction of PD on this type of instrument offers an attractive alternative 
to conventional CID. PD was conducted in the higher energy collision (HCD) cell where 
ions could be trapped and irradiated before being transmitted through the C-trap for 
orbitrap detection.  IRMPD provided an equal or more diverse set of fragment ions 
compared to higher energy CID while also offering selectivity for chromogenic analytes.  
Vacuum ultra-violet photodissociation is a higher energy single photon method to 
fragment peptides and direct fragmentation. The high energy deposition of UVPD leads 
to an extremely diverse set of fragment ions that can provide greater sequence coverage 
as well as side chain cleavages. While it has been found that UVPD in the vacuum range 
is possible for peptides, the sensitivity of the method depends on the photoabsorption 
cross-sections of the peptides, with those peptides that contain aromatic amino acids 





derivatization reagents that were used to enhance the cross-sections of peptides to 
increase their photodissociation effiencies at 193 nm and increase the sensitivity of the 
method. Attachment of aromatic groups to tryptic peptides of BSA illustrated the increase 
in dissociation efficiencies and sequence coverages upon UVPD.  
Electron transfer dissociation has proven to be a complementary technique to 
collision induced dissociation for the analysis of peptides/proteins.  However, ions in low 
charge states predominantly undergo charge reduction without dissociation, thus limiting 
the ability to effectively sequence these peptides. In chapter 6, the selective derivatization 
of cysteines with a quaternary amine (i.e. fixed charge) reagent shifted the charge states 
to higher values by the number of cysteines present in each peptide. The increase in the 
number of charges destabilized the charge-reduced species leading to more prominent 
backbone fragments. In addition, upon ETD a reporter ion was created, thus allowing 
differentiation of cysteine-containing peptides from other peptides in a complex mixture. 
The addition of a fixed charge also increased the ionization efficiencies of derivatized 
peptides, leading to greater detection sensitivity. Three cysteine-alkylation methods were 
compared for a tryptic digest to prove the analytical merits of the fixed charge alkylation 
method. 
Lastly, to demonstrate the ability to use mass spectrometry to gain information 
about a protein’s tertiary structure, chapter 7 discusses a novel derivatization of surface 
accessible amines that upon ETD activation leads to a characteristic fragmentation 
pattern that can be used to quickly identify surface residues. Surface mapping with mass 
spectrometry has been extremely important due to the large number of proteins that prove 





spectrometry only affords low resolution structural analysis, the sample consumption is 
minimal. In addition, with the addition of a preferentially cleavable bond, like a 
hydrazone for ETD, the characteristic fragmentation spectrum created for all modified 
residues eliminated the needle-in-a-haystack data analysis problem that arises when 
trying to identify modified peptides in complex mixtures.  
In summary, CID, IRMPD, UVPD and ETD were utilized to characterize proteins 
derivatization with either a chromophore or a charged moiety. These derivatization 
methods added selectivity to the analytical workflow, ultimately leading to improvements 
in peptide sequence coverage and the ability to target specific types of peptides in 
complex mixtures.   
Future work will focus on utilizing these methods on more complex samples such 
as cell lysates or protein complexes to demonstrate their application in more complex 
proteomic applications. For example, the protein PARP 1 Domain C from chapter 7 is a 
single part of a six part complex and it is only the entire protein complex that proves 
active. PARP-1 ABDEF showed no activity while domain C by itself also remained 
inactive showing that it is the interactions of the entire multi-domain protein that 
stimulate biological activity. Therefore investigating any structural changes upon 
incorporation of Domain C into the macromolecular protein complex would allow 
mapping of the protein-protein interactions. Moreover, the development of other reagents 
that target different amino acid residues would expand the range of applications possible. 
For example, instead of affixing a charge at all cysteine residues, other amino acids that 
are more or less abundant in proteins could be targeted.  Attachment of fixed charge sites 





lead to other trackable reporter ions. In addition, thus far all the work discussed in this 
dissertation was conducted in the positive ionization mode. However, nearly half the 
proteome is acidic, leaving many avenues to be explored that would increase the 
ionization and dissociation of peptide anions. Many new dissociation techniques have 
been developed to improve peptide anion sequencing but many suffer from low 
efficiency or low sequence value, both of which might be overcome through the use of 
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